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The  literature  review  focuses  on  the  research  relating  to  facial  expressions  of 
emotion,  first  addressing  the  question  of what  they  are  and  what  role  they play, 
before going on to review the mechanisms underlying facial expression recognition 
(FER).  It  then  considers  the  psychiatric  and  drug-using populations  in  which  the 
ability to recognise facial expressions is compromised, and how this may impact on 
social  behaviour.  Finally,  the  review  focuses  on  one  particular population:  opiate 
users.  The relevance of studying this population will be discussed and the limited 
evidence relating to recognition of facial expressions in this group will be presented.
The  empirical  paper describes  a study which  investigated FER in an  opiate using 
population,  comparing  methadone  maintained  clients  (MM),  abstinent  ex-opiate 
users  (R)  and healthy controls  (C).  Its main finding was that,  contrary to  existing 
research  predicting  impaired  FER  in  this  population,  MMs  displayed  enhanced 
recognition  of one  emotion:  disgust.  The  literature  around  disgust  recognition  is 
considered,  and characteristics of the opiate-using population that may be relevant 
are  described.  One  speculation  is  that  opiate  users  are  hypersensitive  to  others’ 
expressions  of disgust  due  to  the  negative  reactions  they  encounter  from  society. 
Further research in this area is indicated, and clinical implications discussed.
The critical review comprises a reflective account of the research process, followed 
by a critical appraisal of the study, the main topic of which is the validity of the study 
and directions for future research.
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5Part 1: Literature Review
Abstract
This  literature  review  focuses  on  the  research  relating  to  facial  expressions  of 
emotion,  first  addressing  the  question  of what they  are  and  what  role  they play, 
before going on to review the mechanisms by which they are recognised in others. It 
then  considers  the  psychiatric  and  drug-using populations  in  which the  ability to 
recognise facial expressions is compromised, and how this corresponds to the social 
behaviour  that  characterises  these  groups.  Finally,  this  review  will  focus  on  one 
particular population, opiate users. The relevance of studying this population will be 
discussed and the evidence relating to recognition of facial expressions in this group 
will be presented.
1.  Facial expressions: what are they, why are they and what role do they play?
1.1  What are they?
Research  suggests  that  facial  expressions  of  emotion  are  innate,  automatic  and 
universal  displays  (Ekman  &  Yamey,  2004).  Facial  expressions  are  present  from 
birth and displayed independently of social learning.  Thus babies and congenitally 
blind  people  display  the  same  range  of facial  expressions  as  adults  and  sighted 
people  (Galati,  Scherer & Ricci-Bitti,  1997).  Facial  expressions are thought to be 
produced automatically as a result of impulses generated by the emotional state of 
the individual, although their display can be attenuated or enhanced depending on the 
rules  or  norms  of the  culture  in  which  they  are  produced  (e.g.  Ekman,  1999b). 
Research  has  investigated  the  ‘universality  hypothesis’  (i.e.  that  the  same  basic
6emotions  are  recognised  in  all  cultures;  review  by  Ekman,  1999b).  While  the 
methodology of this research has been criticised by some (Fridlund,  1994; Russell,
1994), the overwhelming evidence is that the same basic emotions are present pan- 
culturally.
Of the wide range of emotions that people experience, a set of basic emotions has 
been identified from which other more complex emotions are thought to be derived 
(Oatley & Johnson-Laird,  1987). While researchers have argued for the inclusion of 
different emotions in this basic  set, the consensus is  for a set of between five and 
seven  basic  emotional  facial  expressions.  Ekman,  Friesen  and  Ellsworth  (1972) 
initially  argued  for the  existence  of six  basic  emotions:  happiness,  sadness,  fear, 
anger, disgust and surprise. Since then, Ekman has added contempt to his list (Ekman 
& Yamey,  2004).  Others,  such as Oatley and Johnson-Laird (1987)  argue  for five 
basic  emotions:  happiness,  sadness,  fear,  anger  and  disgust.  They  challenge  the 
inclusion of surprise on the basis that it is a more cognitive component that could 
accompany any other emotion, rather than being a unique emotion per se (Power & 
Dalgleish,  1997).
“There is robust,  consistent evidence of a distinctive universal facial expression for 
anger, fear,  enjoyment, sadness and disgust.  This evidence is based not just on high 
agreement  across  literate  and preliterate  cultures  in  the  labelling  of what  these 
expressions signal,  but also from studies of the actual expression of emotion,  both 
deliberate  and  spontaneous,  and  the  association  of  expressions  with  social 
interactive contexts. ’’ (Ekman,  1992, pp. 175-176)
7So, why do we have the capacity to automatically display our emotional state? The 
innate and universal nature of facial expressions suggests that there must be  some 
purpose behind their existence and evolutionary continuation.
Looking to other primates provides some clues to the heritage of facial expressions. 
Darwin initiated the  formal  study of facial  expressions in humans and non-human 
primates,  and  concluded  that  they  serve  an  important  communicatory  function 
(Darwin,  1872).  He suggested that displays of facial expression are essential to the 
well-being of any animals living in groups, as group living necessitates co-operation. 
It has been observed that in non-human primates, the range of facial expressions is 
best developed in  species that are active during daytime,  live  in  grasslands  rather 
than trees and live in large and complex social groups (Argyle,  1988). The presence 
of facial  expressions  under  these  conditions  supports  the  idea  that  they  play  an 
important communicatory role. It may be that facial expressions provide a means of 
communication that helps to  regulate  social  structure and hierarchy within groups 
(Argyle,  1988; Keltner & Haidt,  1999). Facial expressions in monkeys are thought to 
be  an  important  part  of  communication  relating  to  submissive,  aggressive  and 
affiliative behaviour as well as to copulation (Argyle,  1988). Interestingly, the same 
facial  configurations  can  be  found  in  humans  and  a  number  of  other  primates 
(Chevalier-Skolnikoff, 1973; Redican, 1982).
This suggests that facial expressions evolved to regulate social behaviour in order to 
facilitate group living in primates.  But how does this relate to the function of facial 
expressions in humans at the present time?1.3  What is their function?
In  his  earlier  work,  Ekman  (1957)  argued  that  while  facial  expressions  might 
communicate to others, this was not their purpose. He believed that although facial 
expressions evolved as a way of imparting information to conspecifics, this did not 
mean that every time an emotion is displayed it acts as a signal to others, particularly 
in  the  present  day.  He  took  the  position  that  expressions  were  generated 
automatically  and  any  communication  that  took  place  was  incidental  and 
unintentional.
More  recently,  Ekman  (1999a)  has  modified  his  view.  He  now  proposes  that 
emotional expressions are crucial to the development and regulation of interpersonal 
relationships.  He  describes  three  areas  in  which  this  is  apparent:  in  attachment 
formation, both during infancy and courtship,  and also  in relation to regulation of 
aggressive behaviour.  He also notes the great difficulty which people with Mobius 
Syndrome  (congenital  face  paralysis)  report  in  sustaining  relationships,  and 
concludes that this is due to their lack of facial expressiveness.
Developmental  psychology  provides  other  examples  of  the  function  of  facial 
expressions.  Facial  expressions  serve  an  important  role  to  infants  who  encounter 
novel objects in the presence of their caregiver. ‘Infant social referencing’ (Klinnert, 
Campos, Source, Emde & Svejda,  1983) refers to the way in which  infants use the 
expressions  and  actions  of their  caregiver  to  understand  events  and  guide  their 
behaviour. For example, if the caregiver shows an expression of disgust or fear, the
9infant avoids the novel object (Blair, 2003).  A similar process occurring in monkeys 
is termed ‘observational fear learning’ (Mineka &Cook,  1993).
Interestingly,  the  display  of  facial  expressions  appears  to  depend  on  the  social 
context  in which they take place,  rather than as  a  function  of the  strength of the 
emotion experienced. Experimental studies show that people smile more on watching 
a humorous video, and show more distress at another’s experience of distress if they 
are  with  others  than  alone  (Fridlund,  1991).  Fridlund’s  (1991)  study  found  that 
participants smiled more when co-viewing a humorous video with a friend, but also 
when  they  thought  that  their  friend  was  watching  the  same  humorous  video 
simultaneously,  compared with two  solitary viewing conditions.  Similarly,  babies’ 
smiling  behaviour  is  thought  to  be  dependent  on  the  presence  of adults  (Jones, 
Collins & Hong,  1991).  Such observations provide further support against the view 
that facial expressions are just an automatically generated reflection of the emotional 
state of the individual.
1.4  What do individual facial expressions communicate?
So what is it that individual facial expressions communicate in humans? Blair (2003) 
argues  that  facial  expressions  act  as  a nonverbal  “short-hand”  for communicating 
important information to peers, in addition to reinforcing behaviour, thus regulating 
appropriate social interaction. Keltner and Haidt (1999) discuss the purpose of facial 
expressions in organising the interactions of individuals at a dyadic level.  Similarly, 
they argue that expressions help individuals to know the other’s emotions, beliefs, 
intentions and orientation towards that relationship (e.g. as a dominant or submissive 
individual) which helps to rapidly co-ordinate social interactions. They also suggest
10that  facial  expressions  of  emotion  convey  information  about  objects  in  the 
environment to conspecifics, and serve as incentives or deterrents for others’  social 
behaviour.
Blair  (2003)  suggests  that  the  facial  expression  of fear  acts  as  an  unconditioned 
stimulus that communicates the aversive nature of an object or situation to others so 
they can avoid it (Mineka & Cook,  1993).  Fear is thought to be the most difficult 
emotion  to  recognise  (Ekman  &  Friesen,  1976),  a  frequent  recognition  error 
involving  misidentifying  fear  for  surprise  (Rapcsak,  Galper,  Comer,  Reminger, 
Nielsen, Kaszniak, et al., 2000). Darwin noted the close relationship between these 
two emotions, pointing out that fear is often preceded by or mixed with surprise, and 
emphasising  the  common  element  of  startle  and  physiological  arousal  (Darwin 
1872).
Expressions  of sadness  are  also  thought  to  act  as  aversive  unconditioned  stimuli, 
discouraging the behaviour that elicited the sadness and motivating reparation (Blair,
1995)  and soothing (Keltner & Haidt,  1999).
The expression of happiness is thought to act as an appetitive unconditioned stimulus 
which  increases  the  probability that  the  behaviour  will  be  repeated  in  the  fixture 
(Matthews  &  Wells,  1999).  Research  suggests  that  happiness  is  the  easiest  and 
quickest facial expression to recognise (Leppanen & Hietanen, 2004; Rapcsak et al., 
2000).
11The facial expression of disgust appears to be most often used in relation to food, to 
quickly  convey  its  aversive  nature  to  others  in  order  to  deal  with  the  risk  of 
contamination  and  disease  (Rozin,  Haidt,  &  McCauley,  1993).  It  has  also  been 
proposed  that  displays  of disgust  may be  important  in  negative  socialisation,  for 
example parental displays of disgust in toilet training (Rozin et al.,  1993).
Interestingly,  to  date,  there  is  no  literature  discussing  the  function  of  facial 
expressions of surprise.
Blair (2003) suggests that the facial expression of anger has a different function from 
the  other  expressions  as  it  does  not  act  as  an  unconditioned  stimulus.  Angry 
expressions  appear to  curtail  the  ongoing  behaviour of others  in  situations  where 
social rules have been violated (Averill, 1982), rather than provide information about 
future behaviour. Blair proposes that expressions of anger primarily act as a trigger 
for response reversal in order to maintain socially appropriate behaviour. It has been 
suggested that expressions of anger are particularly powerful in situations involving 
hierarchy (Blair & Cipolotti, 2000). Displays of anger have also been shown to elicit 
fear-related  responses,  even  when  these  displays  are  presented  subliminally 
(Dimberg & Ohman, 1996).
Ekman  noted  that  people  who  are  unable  to  produce  facial  expressions  have 
difficulty  forming  and  maintaining  social  relationships.  If  there  are  social 
consequences of not displaying expressions of emotion, are there also consequences 
for  those  who’s  ability to  recognise  facial  expressions  is  compromised?  How  do 
people who have difficulty recognising facial expressions fare in the social world?
12The nature of any social difficulties arising from such a deficit would also illuminate 
the role played by facial expressions.
The following section will summarise our current understanding of the way in which 
facial  expressions are recognised,  before going on to review populations in which 
facial  expression  recognition  (FER)  is  impaired.  The  social  behaviour  of  such 
affected populations will also be considered.
2.  The recognition of facial expressions: Mechanism of action
2.1 Neuroanatom  v
The recognition of facial  expressions  is a complex process  involving a number of 
brain  structures.  Much of our current understanding of how  facial  expressions are 
recognised  by  the  brain  is  derived  from  patients  with  lesions  and  neurological 
disorders who have impaired FER, and from imaging studies of both healthy people 
and patients. There is a growing body of literature which suggests that FER depends 
on anatomically dissociable neural systems (Adolphs, 2002).
2.1.1 The amygdala
Research suggests that the amygdala is a crucial structure in FER, particularly in the 
recognition of fear. Patients with amygdaloid lesions have consistently been seen to 
have  impaired  FER,  particularly  for  the  expression  of  fear  (Adolphs,  Tranel, 
Damasio & Damasio,  1995), and also in some studies for sadness (Adolphs, Tranel, 
Hamann, Young, Calder, Anderson et al., 1999; Fine & Blair, 2000).
13Rapcsak  et  al.  (2000)  argue  that  the  research  methodology  that  has  led  to  the 
conclusion that the amygdala is specifically involved in recognition of fear is flawed. 
From the results of their study with lesion patients, they concluded that the amygdala 
is involved in recognition of all facial expressions, and that the appearance of a fear- 
specific deficit is a reflection of how difficult recognition of this particular emotion 
is. Blair (2003) counters this argument, saying that the patients involved in Rapcsak 
et al.’s study had lesions that extended beyond the amygdala which account for the 
difference in findings.
Current  neuroimaging  data  suggests that the  amygdala  is  not  involved  in FER  of 
anger (Blair, Morris, Frith, Perrett & Dolan,  1999; Sprengelmeyer, Rausch, Eysel & 
Przuntek,  1998). There is however neuropsychological data to suggest that lesions of 
the  amygdala,  particularly  if these  extend  to  the  temporal  cortex  do  disrupt  the 
processing of angry expressions (Fine & Blair, 2000). Recognition of happiness does 
not  seem  to  involve  the  amygdala  (Fine  &  Blair,  2000),  although  it  has  been 
suggested that the ease with which happiness is recognised could be a confounding 
factor in this (Ekman & Friesen, 1976).
2.1.2  The pre-frontal cortex
The  pre-frontal  cortex  is  also  implicated  in  FER,  and  seems  to  be  particularly 
important in the recognition of angry expressions.  Homak, Rolls and Wade (1996) 
found that patients with damage to the ventral  frontal lobe demonstrated impaired 
FER,  but  the  authors  did  not  differentiate  between  the  differing  emotional 
expressions.  Blair et al.  (1999)  found increased activation in the orbitofrontal  and
14anterior cingulate cortices when subjects were shown facial expressions of anger, but 
not sadness.  Harmer,  Thilo,  Rothwell and Goodwin (2001c)  found  longer reaction 
times  in  response  to  morphed  angry  (but  not  happy)  facial  expressions,  when 
processing  within  the  medial  prefrontal  cortex  was  disrupted  via  transcranial 
magnetic  stimulation.  Activation  of  this  area  on  presentation  of  angry  faces 
corresponds  with  Blair’s  hypothesis  regarding  this  expression  as  a  trigger  for 
response reversal, as the orbitofrontal cortex is also implicated in this process (Dias, 
Robbins & Roberts,  1996).
2.1.3  Somatosensory related cortices and basal ganglia
Adolphs  (2002)  reviews  the  evidence  from  lesion  studies  investigating  the 
involvement  of the  somatosensory  related  cortices  and  the  basal  ganglia  in  FER, 
concluding that they play a critical role. In a study of patients with lesions in the right 
ventral primary and secondary somatosensory areas, and to a lesser extent the insula 
and anterior supramarginal gyrus, Adolphs, Damasio, Tranel, Cooper and Damasio, 
(2000) found compromised FER. This is consistent with the hypothesis that in order 
to recognise the facial expression of another, we have to first simulate it ourselves, 
and it is this representation of emotion in the somatosensory cortex that allows us to 
infer the emotion of the other (Wild, Erb & Bartels, 2001).
Blair (2003) concludes that the insula (a visceral somatosensory cortex) is key to the 
recognition of disgust, based on lesion and neuro-imaging studies (Cubero, Thiele & 
Bernstein, 1999; Sprengelmeyer et al., 1998). Adolphs’ (2002) review also concludes 
that  the  recognition  of disgust relies  on  the  insula,  with the  support  of the basal
15ganglia (particularly the caudate nucleus) and other somatosensory related cortices in 
the right hemisphere.
2.2  Neurotransmitter involvement
Research  evidence  from  manipulation  studies  suggests  that  there  is  differential 
neurotransmitter involvement in the recognition of different facial expressions (Blair 
& Curran,  1999). To summarise, it seems that serotonin, noradrenaline, GAB A and 
possibly dopamine are involved in FER.
2.2.1  Serotonin
Harmer and colleagues have conducted much of the research investigating the effect 
of serotonin manipulations on FER, with the finding that the expressions of fear and 
happiness are differentially affected. In one study, they found that administration of 
nutritionally  sourced  tryptophan  to  healthy  female  volunteers  led  to  significantly 
increased  recognition  of  fearful  facial  expressions,  as  well  as  (borderline) 
significantly  increased  recognition  of  happy  facial  expressions  (Attenburow, 
Williams, Odontiadis, Reed, Powell & Cowen, 2003). It is assumed that this effect is 
mediated via changes in brain serotonin function.  Similar results were found when 
serotonin  levels  in  healthy  volunteers  were  increased  via  single  injections  of the 
SSRI  antidepressant  citalopram.  Acute  administration  of citalopram  increased the 
accuracy of recognition and decreased the response time in identifying fearful  and 
happy  facial  expressions,  relative  to  placebo  (Harmer,  Bhagwagar,  Cowen  & 
Goodwin, 2001a;  Harmer, Bhagwagar, Perrett, Vollm, Cowen & Goodwin, 2003a).
16In  another  study,  Harmer,  Rodgers,  Tunbridge,  Cowen  and  Goodwin  (2003b) 
decreased serotonin levels in healthy volunteers using a tryptophan depletion drink, 
with  the  result  that  female,  but  not  male  participants  demonstrated  impaired 
recognition of fearful facial expressions. Although accuracy of recognition was only 
impaired  in  the  female  volunteers,  both  male  and  female  volunteers  showed  a 
significantly slower response in recognising fearful facial expressions.
Harmer  et  al.  (2003a)  note  that  the  effects  of serotonin  on  the  threat  perception 
system are counter-intuitive, given that SSRI medications are effective treatments for 
anxiety  disorders  such  as  GAD  and  panic  disorder,  and  conclude  that  acute  and 
chronic SSRI use may have different effects on fear processing. These authors have 
conducted two studies investigating this difference. In the first they found that sub­
chronic (7 day) treatment with citalopram decreased recognition of fearful and other 
negative  facial  expressions  in  healthy  volunteers  (Harmer,  Shelley,  Cowan  & 
Goodwin,  2002a).  The  second study (Harmer,  Shelley,  Cowen &  Goodwin,  2004) 
compared serotonergic and noradrenergic agents with a placebo, with similar results 
to  the  first  study.  Specifically,  participants  treated  with  the  serotonergic  agent 
(citalopram)  showed  decreased  recognition  of anger and  fear,  and  a positive bias 
when  shown  ambiguous  faces.  They  tended  to  classify  negative  expressions  as 
happy, and fearful expressions as surprised.
More recently, Hoshi, Bisla, and Curran (2004) have investigated the acute and sub­
acute  effects  of ‘ecstasy’  (MDMA)  on FER.  While MDMA  causes the release of 
dopamine  and  noradrenaline,  its  main  action is  on the  serotonin  system,  where  it 
stimulates release of stored serotonin and prevents its reuptake (Hoshi et al., 2004).
17In the days following ecstasy use, serotonin is depleted as a result of the initial acute 
efflux. Hoshi and colleagues found that following acute administration of the drug, 
the  ecstasy  using  group  recognised  a  greater number  of fearful  expressions  than 
controls,  but four days  later,  they recognised fewer fearful  facial expressions than 
controls.  This  again  supports  the  involvement  of serotonin  in  the  recognition  of 
fearful facial expressions.
2.2.2  Noradrenaline
Noradrenergic  manipulations  have  been  found  to  have  a  specific  effect  on  the 
recognition of sad and happy facial expressions. Harmer and colleagues administered 
the  adrenergic  beta-blocker  propranolol  to  healthy  volunteers,  and  observed  an 
increased reaction time but no change in accuracy of the identification of sad facial 
expressions,  compared with  a control  group  receiving a placebo  (Harmer, Perrett, 
Cowen  &  Goodwin,  2001b).  Propranolol  did  not  have  an  effect  on  any  other 
expression and  did not cause  any  sedation which  could  account  for the  increased 
reaction  time.  In  contrast,  a  study  by  Zangara,  Blair  and  Curran  (2002)  which 
compared the effects of the beta-blocker metoprolol with diazepam on FER, did not 
find any effect of metoprolol,  either in accuracy or speed of recognition.  They did 
however,  use  a  lower  dose  of beta  blocker  than  Harmer  et  al.  In  another  study, 
Harmer, Hill, Taylor, Cowen and Goodwin (2003c) observed that healthy volunteers 
recognised more happy facial expressions following a single dose of reboxetine (a 
noradrenergic  antidepressant) than those who  received a placebo.  Similarly,  in the 
aforementioned study comparing a serotonergic and noradrenergic agent, Harmer et 
al.  (2004)  found that healthy volunteers given a 7-day course of the noradrenergic
18agent reboxetine showed decreased recognition of anger and fear, and a positive bias 
in classifying ambiguous expressions when compared with a placebo condition.
2.2.3 GAB  A
Evidence for the role of GABA in FER comes from studies with benzodiazepines, 
with  results  suggesting  an  involvement  in  processing  expressions  of  anger  and 
possibly fear. Blair and Curran (1999) used a between subjects design to investigate 
the effects of benzodiazepines on FER,  finding that diazepam selectively impaired 
healthy volunteers’ ability to recognise angry facial expressions. The aforementioned 
study by Zangara et al.  (2002) replicated Blair and Curran’s (1999) study, but with 
the inclusion of a beta blocker comparison group.  Again they found that diazepam 
selectively  impaired  FER  of  anger,  but  on  this  occasion  they  also  found  that 
recognition  of  fear  was  impaired.  They  suggest  several  possibilities  for  this 
discrepancy,  including task difficulty of fear recognition and  an  interaction  effect 
between drug action and mood state.
Borrill, Rosen and Summerfield (1987) investigated the effects of differing doses of 
alcohol,  which  also  has  GABA-ergic  action  (as  well  as  actions  on  several  other 
neurotransmitters), on FER. They found that the high dose of alcohol had a highly 
significant effect impairing the recognition of anger, and also significantly impaired 
recognition of disgust.
2.2.4 Dopamine
To date, only one study regarding the role of dopamine in FER has been published. 
Using  a  within  subject  design,  Lawrence,  Calder,  McGowan  and  Grasby  (2002)
19administered sulpiride (a D2 receptor antagonist) to healthy male volunteers with the 
result that recognition of angry expressions was selectively impaired compared with 
placebo.  They also  included a control task of unfamiliar face matching,  on which 
sulpiride had no effect. The authors discuss these results with reference to appetitive 
aggression  and  social  dominance,  in  which  dopamine  is  also  implicated.  During 
social-agonistic encounters,  dopamine levels have been shown to be elevated (van 
Erp & Miczek, 2000), which seems to reflect increased attention to the provocative 
stimulus or attempts to deal with it.  Acute administration of dopamine antagonists 
selectively  impairs  responses  to  agonistic  encounters  (Redolat,  Brain  &  Simon, 
1991), hence the clinical use of sulpiride as an anti-aggressive agent.
2.3  Summary
To  summarise,  facial  expressions  appear  to  be  processed  by  at  least  partially 
separable  neurocognitive  (Adolphs,  Damasio,  Tranel  &  Damasio,  1996)  and 
pharmacological (Zangara et al., 2002) systems.  Serotonergic manipulations appear 
to affect the processing of fearful and happy facial expressions, while noradrenergic 
manipulations seem to affect processing of sad facial expressions. Both are likely to 
be mediated by the amygdala. GABAergic and possibly dopaminergic manipulations 
(although the evidence is limited at the current time) appear to affect processing of 
angry facial expressions, recognition of which is likely to be mediated prefrontally, 
especially  by  the  orbitofrontal  cortex.  There  is  no  evidence  regarding 
neurotransmitter  involvement  in  disgust,  however  neurological  studies  strongly 
indicate that key structures are the basal ganglia (in particular the caudate), the insula 
and other somatosensory related cortices.
203.  Populations in which FER is impaired
The  literature  reviewed  so  far  suggests  a)  that  being  able  to  recognise  facial 
expressions  has  an  important  social  function,  and  b)  that  this  ability  can  be 
compromised,  either  by  damage  to  those  areas  of the  brain  or  changes  to  the 
neurotransmitters that are involved in FER. With this knowledge, one might predict 
that impaired ability to recognise facial expressions would have social consequences. 
Evidence suggests that psychiatric illness and drug use alters neuropharmacological 
and neurological functioning. The following section will review the literature relating 
to FER in people with psychiatric illness and substance misuse,  and consider how 
this corresponds to social behaviour.
3.1 Psychiatric illness
3.1.1 Schizophrenia
Impaired  FER  in  schizophrenia has been widely documented  (Mandal,  Pandey  & 
Prasad,  1998).  Hall,  Harris,  Sprengelmeyer,  Sprengelmeyer,  Young,  Sanots,  et al. 
(2004)  found  that  schizophrenic  patients  displayed  an  overall  deficit  in  FER 
compared with healthy controls, however they do not report specific effects on the 
different  expressions.  They also  found that when they divided their schizophrenic 
group  into  those  with  and  without positive  symptoms,  it  was  those  patients  with 
positive symptoms that contributed most to this deficit. Similarly, other studies have 
found  a  negative  correlation  between  psychotic  symptoms  and  FER  accuracy 
(Schneider,  Gur,  Gur & Shtasel,  1995). Kohler, Turner, Bilker, Brensinger,  Siegel, 
Kanes,  et al.  (2003)  assessed FER in stable  schizophrenic patients and found that 
overall,  their  schizophrenic  patients  had  impaired  FER,  particularly  for  the
21expression of fear and disgust. These patients also misinterpreted neutral expressions 
as emotional more often than controls, showing a negative bias. The authors discuss 
the  meaning  of  this  in  relation  to  understanding  psychotic  symptoms,  such  as 
perceiving neutral events as personally significant.
Phase of illness has also been found to differentiate schizophrenic patients’ ability to 
recognise facial expressions, with remitted patients performing better than those who 
are  acutely unwell  (Gessler,  Cutting,  Frith & Weinman,  1989).  Patients  with  first 
episode psychosis  have  been  found to  perform  worse  than patients  with  affective 
psychosis  and  control  subjects,  especially  on  recognition  of  fear  and  sadness 
(Edwards, Pattison, Jackson & Wales,  2001).
Poor interpersonal functioning characterises this patient group (Hall et al., 2004), and 
it  has  been  suggested  that  inaccurate  recognition  of emotions  may  underlie  this 
(Poole,  Tobias  &  Vinogradov,  2000).  In  addition  to  looking  at  FER,  the 
aforementioned  study  by  Hall  et  al.  also  assessed  social  cognition  in  their 
schizophrenic participants, finding highly significant impairments across tests of this 
domain.
3.1.2  Bipolar Disorder
Less research has been conducted with patients with a diagnosis of bipolar disorder. 
The results of a study by Lembke and Ketter (2002) suggest that manic patients have 
worse  overall  recognition  of  facial  expressions  than  euthymic  subjects  with  a 
diagnosis of bipolar disorder and healthy controls, particularly for the expressions of 
fear  and  disgust.  These  authors  found  a  tendency  for  manic  patients  to  mistake
22disgust for anger, and fear for surprise, and relate this to aspects of social interaction 
which  characterise  manic  patients,  such  as  persistent  approach  behaviours. 
Interestingly, recognition of happiness was completely preserved in manic patients, 
and there was  a negative  correlation between  scores  on the Young Mania Rating 
Scale and recognition of sad faces. This suggests that the ability to recognise emotion 
may vary with the degree of mood disturbance.
McClure, Pope, Hoberman, Pine and Leibenluft (2003) investigated how accurately 
adolescents with bipolar disorder recognised the facial expressions of both peers and 
adults.  They  found  that  bipolar  patients  performed  worse  on  FER  than  anxious 
adolescents  and  healthy  comparison  subjects.  The  bipolar adolescents  were  more 
likely to misinterpret the happy,  sad and fearful expressions of the peers as angry, 
however this impairment was not present for the faces of adults. The authors do not 
state  whether their participants were manic,  euthymic or depressed  at the time of 
testing.  McClure  et  al.  propose  that  such  a  bias  in  FER  may predispose  such  a 
population to negative peer interactions.
A  study  with  slightly  different  findings  was  conducted  by  Harmer,  Grayson  and 
Goodwin  (2002b).  While  they  found  generally  impaired  FER  performance  in 
euthymic bipolar patients compared with healthy controls, enhanced recognition of 
disgust  was  displayed  and  fewer  false  positive  disgust  expression  identifications 
were made.  The authors discuss the impact of bipolar mood disorder on the basal 
ganglia, in particular the caudate, both known to be involved in processing disgust 
reactions.  Neuroimaging studies  suggest that  caudate volume may be increased in 
bipolar patients relative to matched controls (Aylward, Roberts-Twillie, Barta, Kumr,
23Harris, Geer, et al.,  1995), in addition to increased levels of neural activity within the 
caudate during periods of acute mania (Blumberg, Stem, Martinez, Ricketts, de Asis, 
White, et al., 2000). They also consider whether more accurate recognition of disgust 
could be associated with the negative self-perception that has been found in bipolar 
patients (Lyon, Startup & Bentall,  1999), in particular low self-esteem and increased 
anxiety. However, they do not elucidate the mechanism by which this could happen.
3.1.3  Depression
Research with depressed participants has looked at both the accuracy of FER and 
also  how  FER  is  related  to  the  course  of  depressive  illness.  The  evidence  is 
somewhat inconsistent, but tends to point to impaired overall FER relative to non­
depressed  controls  (Gur,  Erwin,  Gur,  Zwil,  Heimberg  &  Kraemer,  1992).  Which 
emotions are specifically impaired varies between studies.  A negative bias in FER 
has been demonstrated with depressed participants  (Rubinow & Post,  1992;  Hale, 
1998),  and  some  studies  suggest  a  correlation  between  depressed  mood  and 
negatively biased impaired FER (Gur et al.,  1992). It may be that one of the effects 
of antidepressant medication is to correct this negative information processing bias, 
as suggested by Harmer et al.’s (2003c) study in which reboxetine was administered 
to healthy volunteers, producing a positive recognition bias.
Hale (1998)  found that depressed patients tended to judge facial  expressions more 
negatively  (i.e.  they  identified  more  negative  than positive  expressions),  and  saw 
more sadness in the faces, whether the expressions were ambiguous (i.e. mixed with 
other emotions) or not. Interestingly, he also found that the disposition to judge facial 
expressions negatively,  in both ambiguous and non-ambiguous faces was  strongly
24correlated with the  severity and persistence of their depressive illness.  In contrast, 
Bouhuys, Geerts, Mersch and Jenner (1996) found that the depressed patients in their 
study  who  were  less  sensitive  to  expressions  of  sadness,  rejection  or  anger  on 
admission  experienced  less  symptomatic  improvement  over  the  course  of  their 
depressive episode.
Both sets of authors hypothesise about the role of facial expression decoding abilities 
in  the  interpersonal  relationships  of  depressed  patients.  Hale  cites  Gotlib  and 
Hamen’s (1992) suggestion that the negative expectancies of depressed people, and 
readiness  to  attend  to  negative  aspects  of their  social  surroundings  may  lead  to 
feelings of rejection, resulting in decreased social support. In this way, their negative 
perception of others’ potentially ambiguous facial expressions may account for their 
interpersonal difficulties. On the other hand, on the basis of their findings, Bouhuys 
et  al.  hypothesise  that  hyposensitivity  to  others’  facial  expressions  is  related  to 
persistence of depression via a similar mechanism. They discuss the possibility that 
depressed  people  who  are  less  able  to  perceive  negative  emotions  of others  will 
engage in more unwelcome help-seeking behaviour, resulting in rejection.
S.  1.4 Obsessive-Compulsive Disorder (OCD)
The  research  evidence  pertaining  to  impaired  FER  in  patients  with  OCD  is 
inconsistent,  possibly  due  to  the  heterogeneous  nature  of  the  disorder. 
Sprengelmeyer,  Young, Pundt,  Sprengelmeyer,  Calder, Berrios,  et al.  (1997) found 
that  patients  with  OCD  and  patients  with  Tourette’s  syndrome  accompanied  by 
obsessive  or compulsive behaviours  exhibited  impaired disgust recognition,  while 
patients with Tourette’s syndrome but no OCD features did not. The authors found
25that  patients  with  OCD  or  OCD  features  frequently  misclassified  expressions  of 
disgust  as  anger.  Patients  with  anxiety  disorders  (panic  disorder  or  GAD)  were 
comparable to healthy controls in their recognition of disgust.
In  contrast,  Parker,  McNally,  Nakayama,  and  Wilhelm  (2004)  failed  to  replicate 
these results,  finding no significant differences between OCD patients and healthy 
control  subjects.  Only  one  of their OCD  participants  displayed  a  specific  disgust 
recognition deficit, who interestingly was the participant with the most severe OCD 
symptomatology.  They conclude that the  impairments may only occur in cases of 
severe OCD.  Two other studies have used OCD patients and healthy volunteers as 
control groups when looking at FER in detoxified alcoholics and Body Dysmorphic 
Disorder (Komreich, Blairy, Philippot, Dan, Foisy, Le Bon, et al. 2001a; Buhlmann, 
McNally,  Etcoff,  Tuschen-Caffier & Wilhelm.,  2004,  respectively).  Neither found 
impaired  disgust recognition in their OCD  sample.  A  further study by Montagne, 
Kessels, de Geus, Denys, de Haan and Westenberg (2005) found that OCD patients 
were more sensitive to all emotional expressions than healthy controls, but failed to 
find a disgust-specific effect in the group as a whole. However, their results showed 
that  those  OCD  patients  with  more  severe  symptomatology  demonstrated  more 
accurate disgust recognition than controls.
There  is  evidence  to  suggest  that  abnormalities  exist  in  the  basal  ganglia  of 
obsessive-compulsive disorder patients (Parker et al., 2004), the basal ganglia also 
being  implicated  in the processing of disgust  expressions  (Adolphs,  2002).  It has 
been suggested that abnormal experience of disgust may be involved in the genesis 
of obsessions and compulsions (Power & Dalgleish,  1997), as so many OCD patients
26exhibit heightened disgust in reaction to stimuli they regard as contaminated (Parker 
et  al.,  2004).  Intuitively,  it  might  be  expected  that  OCD  patients  would  be 
hypersensitive to disgust cues, however the research in this area is inconclusive.
3.1.5  Psychopathy and Acquired Sociopathy
People  diagnosed  with  psychopathy  have  been  found  to  demonstrate  markedly 
impaired FER for fear and sadness (Blair, Colledge, Murray & Mitchell, 2001) and 
also  disgust  (Kosson,  Suchy,  Mayer &  Libby,  2002).  The  case  of psychopathy is 
particularly  interesting  when  considering  the  impact  of impaired  FER  on  social 
behaviour,  given that antisocial behaviour and unstable relationships are diagnostic 
markers for psychopathy. It is proposed that psychopathic individuals have a limited 
capacity  for  understanding  and  experiencing  emotion,  anticipating  the  emotional 
consequences  of their behaviour and do  not learn  from punishment (Blair,  2001). 
Blair’s  (1995)  account  of  psychopathy  links  the  condition  to  early  amygdala 
dysfunction and consequent impairments in processing fearful and sad emotions. It 
has been found that compared with normal individuals, psychopaths show reduced 
activation  of  the  amygdala  during  aversive  conditioning  tasks  (Veit,  Flor,  Erb, 
Hermann, Lotze, Grodd & Birbaumer, 2002). Unlike non-psychopaths, psychopaths 
also  fail  to  exhibit  startle  potentiation  while  viewing  slides  depicting  mutilation 
(Levenston,  Patrick,  Bradley & Lang,  2000).  If,  as has been suggested,  disgust is 
important in negative socialisation, longstanding insensitivity to other’s disgust could 
conceivably contribute to poorly socialised behaviour,  as seen in the psychopathic 
population.
27Damasio,  Tranel and Damasio (1990)  introduced the term  ‘acquired sociopath’, to 
refer to individuals who, following acquired lesions to the orbitofrontal cortex, fulfil 
criteria for DSM-III diagnosis of sociopathic disorder. Such individuals present with 
frustration or threat induced reactive aggression (Blair & Cipolotti, 2000). Acquired 
sociopaths have been found to display generally impaired FER, but particularly for 
expressions of anger (Blair & Cipolotti, 2000; Homak, Rolls & Wade,  1996).  This 
finding  is  consistent  with  the  hypothesis  that  areas  of the  preffontal  cortex  are 
responsible for recognising and responding to expressions of anger.
3.2  Drugs and Alcohol 
3.2. J Alcohol
Alcohol  appears  to  have  different  effects  on  FER  depending  on  the  dose 
administered. As mentioned in 2.2.3, acute high dose alcohol use appears to have a 
significant  impact  on  FER  in  normal  social  drinkers,  particularly  affecting  the 
recognition of anger (Borrill et al.,  1987). However, in low doses, alcohol has been 
found  to  enhance  FER  (Borrill  et al.,  1987).  Kano,  Gyoba,  Kamachi,  Mochizuki, 
Hongo  and  Yanai  (2003)  found  that  administration  of a  low  dose  of alcohol  to 
healthy young men was associated with significantly better discrimination of happy 
faces,  but that  this  performance  deteriorated  with  higher  doses.  This  corresponds 
with the  differential  effects of alcohol  at high and low doses on social behaviour. 
Initially alcohol increases sociability and talkativeness (Kano et al., 2003), while at 
higher doses it is related to interpersonal aggression (Chermack & Giancola,  1997) 
and poor  interpersonal  functioning  (Komreich,  Philippot,  Foisy,  Blairy,  Raynaud, 
Dan, et al., 2002).
28Chronic alcohol use has also been associated with both poor FER (Komreich, Blairy, 
Philippot, Dan, Foisy, Le Bon, et al., 2001a) and interpersonal difficulties (Komreich 
et al.,  2002).  Philippot, Komreich, Blairy,  Baert, Den Dulk, Le Bon,  et al.,  (1999) 
found  impaired  FER  in recently  detoxified  alcoholics,  with  significant  deficits  in 
recognising anger,  sadness, happiness and disgust and a special bias towards over­
attribution of anger and contempt.  Similarly,  Townshend and Duka (2003) found a 
group difference between two-week detoxified alcoholic patients and controls in the 
recognition  of  anger  and  disgust.  The  alcoholic  group  underestimated  the 
presentation  of anger  compared  to  controls,  frequently  misidentifying  disgust  as 
anger.  Research has also found that recently detoxified alcoholics overestimate the 
emotional intensity of facial stimuli (Oscar-Berman, Hancock, Mildwordf, Hutner 
&  Altman-Weber,  1990;  Philippot  et  al.,  1999;  Verbanck,  2001).  Furthermore, 
deficits  in  recognition  of anger,  disgust  and  to  a  lesser extent  sadness,  appear to 
persist even after abstinence from alcohol of two months or more. Verbanck (2001) 
found specifically impaired anger and disgust recognition in alcoholics who had been 
detoxified for at least 2-months, compared with healthy controls. In contrast, ratings 
of  emotional  intensity  return  to  the  level  of  normal  controls  with  abstinence 
(Komreich et al.,  2001;  Verbanck, 2001).  Komreich et al.,  (2002)  found that self- 
reported  interpersonal  difficulties  correlated  with  FER  deficits  in  a  sample  of 30 
alcoholics, although no causal relationship can be inferred from this.
3.2.2  Ecstasy
Research with ecstasy users and FER is still in its infancy. As already mentioned in 
2.2.1,  Hoshi  et  al.  (2004)  found  that  ecstasy  use  impacted  on  fear  recognition, 
enhancing  recognition  of  fearful  expressions  following  acute  administration  and
29impairing this ability four days later. Hoshi et al. also used a measure of aggression 
at these two time points, with the finding that users had higher self rated aggression 
scores than controls at day 4, despite there being no difference in this rating on the 
night of drug use.
3.2.3 Benzodiazepines
As already reviewed in 2.2.3, benzodiazepines have been seen to selectively impair 
the recognition of anger (Blair & Curran,  1999), and in one study also fear (Zangara 
et  al.,  2002).  While benzodiazepines  are used  for their anxiolytic properties,  they 
have been noted to have ‘paradoxical’ side-effects such as disinhibition, hostility and 
aggression.  Chronic  alprazolam  use  has  been  found  to  increase  behavioural 
aggression  in  lab  settings,  particularly  under  conditions  of  provocation  (Bond, 
Curran,  Bruce,  O’Sullivan  &  Shine,  1995).  However,  this  is  not  accompanied by 
subjective ratings of increased anger or hostility, reflecting a lack of insight into the 
emotional changes.
3.3 Summary
In  summary,  FER  is  impaired  in  many  psychiatric  and  drug-using  populations. 
Impairments  can be  general,  affecting the  accuracy of recognition of many or all 
expressions  (e.g.  in  schizophrenia),  and  also  specific  to  certain  emotions  (e.g.  in 
psychopathy and with acute use of benzodiazepines).  Broadly-speaking,  it appears 
that  those  populations  which demonstrate  impaired recognition  of anger and  fear 
(e.g. psychopaths, manic patients, alcohol and benzodiazepine use) are characterised 
by  less  sensitive  social  behaviour.  This  generally  seems  to  take  the  form  of 
aggressive  or  persistent  approach  behaviours.  Impaired  recognition  of  sad
30expressions (e.g. in manic patients, and in some depressed patients) also appears to 
be  associated  with  poor  social  behaviour  and  a  less  favourable  outcome  in 
depression.
It also appears that several populations show interpretation biases (e.g.  depressed, 
bipolar and alcoholic patients), and that these biases may correspond to mood state, 
social behaviour and course of illness in the case of depression.
Other  populations  demonstrate  enhanced  FER  (e.g.  enhanced  recognition  of 
happiness with low dose alcohol use and acute antidepressant treatment) which may 
correspond to prosocial behaviour and improved mood state.
4.  Opiate Use
One  major class  of drugs  which  is  underrepresented  in  the  literature  on  emotion 
processing  is  that  of opiates.  Morphine,  codeine,  heroin  and  methadone  are  all 
opiates that are widely used for pain relief, as drugs of abuse or as treatment for drug 
abuse.  The  prevalence  of heroin  use  is  hard  to  gauge  as  it  is  largely  a  hidden 
problem. However, a recent estimation suggested a prevalence of 3.7% among men 
aged  25-44  in  London  (Hickman,  Higgins,  Hope  &  Beilis,  2004).  Every  year, 
community pharmacies across England dispense over 1.25 million NHS prescriptions 
for methadone, suggesting that about 50,000 opiate users are receiving methadone at 
any one time (Strang & Sheridan, 2003).  Despite such high levels of use, we know 
relatively little about the effects of this class of drug upon psychological functioning. 
It  is  of  note  that  heroin  use  almost  never  occurs  in  isolation,  with  cocaine,
31amphetamines and benzodiazepines also being widely used by drug misusers seeking 
treatment for heroin dependence (Gossop, 2005). The National Treatment Outcomes 
Research  Study (Gossop,  Marsden,  Stewart,  Lehmann,  Edwards,  Wilson &  Segar, 
1998) found that almost two thirds of drug users in treatment had been using three or 
more  substances before admission to treatment,  and more than a third were using 
stimulants  on  a  frequent  basis.  The  most  commonly  used  stimulant  among  drug 
misusers seeking treatment for heroin dependence was crack cocaine (Gossop et al., 
1998).
4.1  Different kinds of opiates
Opiates  can  be  classified  into  two  fundamentally  different  groups;  morphine-like 
agonists and opiates producing mixed actions. Morphine-like agonists act primarily 
at mu receptors, but also at kappa and delta receptors. They are strong analgesics, 
indicated  for  use  in  clinical  situations  requiring  moderate  to  severe  pain  relief. 
Morphine,  heroin  and  methadone  are  examples  of opiates  in  this  class.  Opioids 
producing  mixed  actions  are  associated  with  a  lower  level  of analgesia,  and  are 
clinically indicated for mild to moderate pain.  They can be subdivided into mixed 
agonist-antagonist such as buprenorphine, and partial agonists such as codeine.
Treatment of heroin abuse involves substituting longer acting morphine-like agonists 
such as methadone for heroin (Zacny,  1995). There is now substantial evidence for 
the  effectiveness  of methadone  maintenance  treatment  for  opiate  users  (National 
Treatment  Agency,  2004).  Methadone  treatment  is  also  associated  with 
improvements in health and social functioning, lower levels of crime and a lower risk 
of premature mortality (National Treatment Agency, 2004).
324.2 Neuropharmacological Action of opiates
Like virtually all drugs of abuse,  opiates enhance dopamine release in the nucleus 
accumbens by increasing the activity of dopamine neurons in the ventral tegmental 
area.  It  is  thought  that  opiates  activate  mu  opioid  receptors  located  on  GABA 
neurons within the ventral tegmental area. Opiates also have dopamine-independent 
effects within the nucleus accumbens, which play an important part in opiate reward. 
Pharmacological challenges with drugs that interact with dopamine receptors have 
demonstrated that the activity of brain dopaminergic systems is altered by long term 
opiate use in heroin addicts ( Casas, Guardia, Prat & Trujols, 1995).
4.3 Interpersonal functioning and personality in opiate users
Most opiate users  seeking treatment present with a range  of difficulties  including 
severe  family  and  social  problems  (National  Treatment Agency,  2004).  Research 
indicates  that  poor  interpersonal  functioning  is  present  among  opiate  users 
(Meulenbeek, 2000).
Increased  aggression  is  one  of  the  primary  features  discussed  in  the  literature 
surrounding  opiate  users’  interpersonal  functioning,  although  with  inconsistent 
research findings.  Hoaken (2003) highlights four possible reasons for the existence 
of a relationship between drug use and aggression. Firstly, aggression may be a result 
of the direct action of the drug on behaviour.  Secondly, aggression may be used to 
get drugs or get the resources necessary to buy drugs. Thirdly, aggression and drug 
use may both be the result of a personality factor such as high sensation-seeking or 
impulsivity. Lastly, withdrawal effects of the drug may increase aggression.
33While animal research suggests that opiates temporarily reduce aggressive behaviour 
(e.g. Miczek, Weerts & DeBold, 1993), controlled human studies have demonstrated 
heightened aggression on laboratory measures in participants administered codeine 
(Spiga, Cherek, Roache & Cowan,  1990) and morphine (Berman, Taylor & Marged, 
1993)  compared  to  controls.  In  a  more  naturalistic  study,  Morentin,  Callado  and 
Meana (1998) reviewed the files of 578 arrestees in Spain,  concluding that among 
those  who  used  heroin,  aggression  towards  arresting  police  or  non-fatal  violent 
offences against other people were less frequent than among arrestees with no drug 
or psychiatric history. In contrast, Gerra, Amir, Raggi, Giusti, Delsignore, Bertacca 
and  Brambilla  (2001)  found  increased  aggression  in  methadone  maintained 
participants  compared  with  healthy  controls,  using  a  laboratory  measure  of 
aggression, but concluded that this was more related to personality traits than drug 
effects.
Fassino, Daga, Delsedime, Rogna & Goggio (2004) summarise the main conclusions 
drawn  from  research  which  has  sought  to  classify the  personality  type  of heroin 
users.  Firstly,  personality  disorder  is  commonly  found  in  heroin  users,  with 
prevalence  figures  of around  50%,  in  which borderline,  antisocial  and  dependent 
types are over-represented (Fassino et al., 2004).  Secondly, two subtypes of heroin 
users have been identified; the first characterised by a low level of psychopathology 
and  good  relational  skills,  and  a  second with high  levels  of personality disorder, 
severe relational difficulties and a worse prognosis.
34A dimensional approach has also been taken to identify specific personality traits of 
heroin users, with Khantzian (1997) suggesting that heroin users are “immature and 
unable to take care of themselves”. Other studies propose that users have poor self­
esteem  (Fieldman,  Woolfolk  &  Allen,  1995),  unstable  personal  relationships  and 
identities  (Fassino,  Scarso,  Barbero,  Taylor,  Pezzini  &  Furlan,  1992)  and poorly 
regulated  emotions  and  impulse  control  (Bartholomew,  Sher  &  Wood,  2000; 
Conway, Kane, Ball, Poling & Rounsaville, 2003).
4.4  Opiates and recognition of facial expressions
The  literature  reviewed  so  far  demonstrates  that  FER  is  impaired  in  many 
populations  that  are  characterised by poor social behaviour.  Moreover,  it suggests 
that the specific nature of the FER impairment may be connected to the type of social 
functioning deficit. Given the interpersonal difficulties encountered by opiate users, 
in addition to the pharmacological changes that are brought about by opiate use, it is 
possible that accuracy (and/or speed) of FER is affected in this population.
The only published study in this area is by Komreich, Foisy, Philippot, Tecco, Noel, 
Hess, et al. (2003), who compared FER in five groups of participants:  1) methadone 
maintained,  2)  recently  detoxified  alcoholics,  3)  recently  detoxified  alcohol  and 
opiate users, 4) recently detoxified opiate users and 5) normal controls. They found 
that the recently detoxified alcoholic group and mixed detoxified alcohol and opiate 
group  scored  significantly  lower  on  accuracy  of FER  than  normal  controls.  The 
methadone maintained group and recently detoxified opiate group  accuracy scores 
were  better  than  those  of  the  mixed  detoxified  alcohol  and  opiate  group  and 
detoxified alcohol only group, but worse than the normal controls. Unfortunately this
35study did not differentiate between the individual emotional expressions. The authors 
also  found  that  the  length  of  abstinence  in  the  opiate  abstinent  group  did  not 
influence  FER  scores.  This  could  be  taken  to  mean  that  opiates  do  not  have  a 
detrimental effect on FER and that pre-existing deficits account for the lower scores 
than normal controls, or that the impairments caused by opiate use persist long after 
discontinuation, as was found with alcoholic subjects (Komreich et al., 2001).  The 
lack of research investigating specific FER impairments in opiate users constitutes a 
significant  gap  in  the  literature,  given  the  prevalence  of opiate  use  today.  Any 
significant findings could be of use in better understanding the specific difficulties 
faced by opiate users, and may provide a target for intervention.
5.  Methodological issues in the study of FER
The differing methodology used by studies of FER make it more difficult to draw the 
literature together conclusively. Different versions of the faces task have been used 
across studies. Some researchers (e.g. Bouhuys et al.,  1996; Hale,  1998) have used a 
set of 12 schematic faces (i.e. line drawings) where the key differential features are 
eyebrow  and  mouth  types.  They  argue  that  the  recognition  of  emotional  facial 
expressions  is  of such  importance  that  expressions  can  be  detected  from  highly 
abstract facial displays, and that line drawings are free from cultural differences in 
interpretation. Other studies have used photographs of different people (of different 
gender and race),  each depicting one of the six expressions.  It has been suggested 
that this  method may introduce  factors  other than expression that  could influence 
participants’ judgement of emotions, such as the age, gender and/or attractiveness of 
the photographed person (Hale,  1998). The range of expressions used in faces tasks
36also  varies,  with  some  looking  only  at  selected  emotions  (e.g.  McClure,  Pope, 
Hoberman, Pine & Leibenluft, 2003; Surguladze, Young, Senior, Brebion, Travis & 
Phillips, 2004), some just looking at overall impairment (e.g. Komreich et al., 2003), 
and  some  investigating  all  of the  six  basic  emotions  (e.g.  Hoshi  et al.,  2004).  A 
useful extension of the basic expression recognition paradigm that has been used by 
several  researchers,  is the  investigation of specific misidentification  error patterns 
(e.g.  Lembke & Ketter, 2002) which can provide information about specific biases 
present in populations. A further variant is the separation of facial expressions into 
high and low intensity stimuli (e.g. Kohler et al., 2003), in order to look at whether 
impairments are present for subtle expressions.
The  most  sophisticated  version  of  the  faces  task  uses  stimuli  from  the  Facial 
Expressions  of  Emotions:  Stimuli  and  Tests  (FEEST;  Young,  Perrett,  Calder, 
Sprengelmeyer &  Ekman,  2002),  and  is being  increasingly used  in  FER research 
(e.g.  Harrner  et  al.,  2001;  2003a;  Hoshi  et  al.,  2004;  Lawrence  et  al.,  2002).  It 
consists  of a  set  of photographs  from  the  Ekman  and  Freisen  (1976)  series,  and 
shows 30 photographs of a single individual displaying different expressions that are 
morphed  together  to  differing  degrees.  This  creates  subtle  blends  of expressions 
which  require  more  stringent  discrimination,  and  the  use  of a  single  individual 
reduces response variability. This version of the task also looks at response reaction 
time  in  addition  to  accuracy  of recognition,  which  allows  for  more  meaningful 
interpretation of results, for example detection of speed-accuracy trade-offs.
In  summary,  there  are  various  tools  available  for  investigating  facial  expression 
recognition,  some of which may be better suited to certain research questions than
37others. However, for looking at expression-specific impairments, the FEEST (Young 
et al.,  2002)  provides  a  comprehensive measure  of FER which  is  able to pick up 
subtle deficits.
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57Part 2: Enhanced recognition of facial expressions of disgust in opiate users
Abstract
Impaired recognition of facial expressions (FER) has been found in many psychiatric 
and drug-using populations.  It has been proposed that this deficit may underlie the 
poor  interpersonal  functioning  seen  in  such  populations.  This  study  set  out  to 
investigate FER in opiate users, a client group in which interpersonal difficulties are 
commonly  seen.  20  methadone  maintained  clients  (MM),  20  abstinent  ex-opiate 
users (R) and 21  healthy controls  (C) were compared on a test of FER looking at 
accuracy and reaction time to recognise pictures of the  six basic  emotional  facial 
expressions  morphed  together  to  varying  degrees.  Self-report  measures  of 
aggression,  impulsivity,  mood  and  socialisation  were  also  used  to  compare  the 
different  group  profiles.  The  main  findings  were  that MM  were  not  significantly 
impaired  in  recognising  any  emotion,  instead  showing  significantly  enhanced 
recognition of disgust over R (and non-signiflcantly over C).  The literature around 
disgust recognition is considered, and characteristics of the opiate-using population 
that  may  be  relevant  are  described.  One  speculation  is  that  opiate  users  are 
hypersensitive to  others’  expressions  of disgust due to the negative reactions they 
encounter  from  society.  Further  research  in  this  area  is  indicated,  and  clinical 
implications discussed.
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Facial expressions of emotion are innate, automatic and universal displays (Ekman & 
Yamey, 2004), which can be attenuated or enhanced depending on the rules or norms 
of the culture in which they are produced (e.g. Ekman, 1999).  Of the wide range of 
emotions  that people  experience,  a  set of six basic  emotions  has  been identified: 
happiness,  sadness,  fear,  anger,  disgust  and  surprise,  from  which  more  complex 
emotions  are  thought to be derived  (Oatley &  Johnson-Laird,  1987).  Blair (2003) 
argues  that  facial  expressions  act as  a nonverbal “short-hand”  for communicating 
important information to peers, in addition to reinforcing behaviour, thus regulating 
appropriate social interaction. It is likely that facial expressions provide a means of 
communication that helps to regulate  social  structure and  hierarchy within groups 
(Argyle, 1988; Keltner & Haidt, 1999).
Blair  (2003)  suggests  that the  facial  expression  of fear  acts  as  an  unconditioned 
stimulus that communicates the aversive nature of an object or situation to others so 
they can avoid it (Mineka & Cook,  1993). Expressions of sadness are also thought to 
act  as  aversive unconditioned stimuli,  discouraging the behaviour that elicited the 
sadness  and  motivating  reparation  (Blair,  1995)  and  soothing  (Keltner  &  Haidt, 
1999). The expression of happiness is thought to act as an appetitive unconditioned 
stimulus which increases the probability that the behaviour will be repeated in the 
future  (Matthews  &  Wells,  1999).  The  facial  expression  of disgust  appears to  be 
most often used in relation to food, to quickly convey its aversive nature to others in 
order to deal with the risk of contamination and disease (Rozin, Haidt & McCauley, 
1993).  It  has  also  been  proposed  that  displays  of disgust  may  be  important  in
59negative  socialisation,  for  example  parental  displays  of disgust  in  toilet  training 
(Rozin et al.,  1993).  Interestingly,  there is no  literature  discussing the  function of 
facial  expressions  of surprise.  Blair (2003)  suggests  that the  facial  expression  of 
anger has a different function from the other expressions as  it does not act as an 
unconditioned stimulus. Angry expressions appear to curtail the ongoing behaviour 
of others  in  situations  where  social rules have been violated (Averill,  1982),  thus 
maintaining socially appropriate behaviour. It has been suggested that expressions of 
anger are particularly powerful in situations involving hierarchy (Blair & Cipolotti, 
2000).
There is a growing body of literature which suggests that the recognition of facial 
expressions  is  a  complex process  involving  a number of anatomically dissociable 
neural systems (Adolphs, 2002), in particular the amygdala, the prefrontal cortex, the 
somatosensory related cortices and basal ganglia. Patients with amygdaloid lesions 
have consistently been seen to have impaired facial expression recognition (FER), 
particularly for the expression of fear (Adolphs, Tranel, Damasio & Damasio, 1995). 
The pre-frontal cortex seems to be particularly important in the recognition of angry 
expressions (Blair, Morris, Frith, Perrett & Dolan,  1999). Activation of this area on 
presentation  of  angry  faces  corresponds  with  Blair’s  hypothesis  regarding  this 
expression  as  a  trigger  for  response  reversal,  as  the  orbitofrontal  cortex  is  also 
implicated in this process (Dias, Robbins & Roberts,  1996).  Research consistently 
concludes that the insula (a visceral somatosensory cortex) is key to the recognition 
of disgust, based on lesion and neuro-imaging studies (Blair, 2003; Cubero, Thiele & 
Bernstein,  1999; Sprengelmeyer, Rausch, Eysel & Przuntek,  1998). Adolphs’ (2002) 
review also  concludes that the recognition of disgust relies on the insula, with the
60support  of  the  basal  ganglia  (particularly  the  caudate  nucleus)  and  other 
somatosensory related cortices in the right hemisphere.
Research  evidence  from  pharmacological  studies  suggests  that  there  is  also 
differential  neurotransmitter  involvement  in  the  recognition  of  different  facial 
expressions (Blair & Curran,  1999). To summarise, it seems that serotonin (Harmer, 
Bhagwagar,  Cowen  &  Goodwin,  2001a;  Harmer,  Bhagwagar,  Perrett,  Vollm, 
Cowen  &  Goodwin,  2003a),  noradrenaline  (Harmer,  Hill,  Taylor,  Cowen  and 
Goodwin,  2003c;  Harmer,  Perrett,  Cowen  &  Goodwin,  2001b),  GABA  (Blair  & 
Curran,  1999;  Zangara,  Blair & Curran,  2002)  and possibly dopamine  (Lawrence, 
Calder, McGowan & Grasby, 2002) are involved in FER.
Impaired FER has been found in those affected by psychiatric illness.  It has been 
hypothesised  that  this  may  underlie  the  poor  interpersonal  functioning  that 
characterises  such populations (Poole,  Tobias  & Vinogradov,  2000).  For example, 
deficits  have  been  noted  in  schizophrenia  (Hall,  Harris,  Sprengelmeyer, 
Sprengelmeyer,  Young,  Sanots,  et  al.,  2004;  Kohler,  Turner,  Bilker,  Brensinger, 
Siegel,  Kanes  et al.,  2003;  Mandal,  Pandey  & Prasad,  1998),  the manic phase  of 
bipolar  disorder  (Lembke  &  Ketter,  2002),  depression  (Gur,  Erwin,  Gur,  Zwil, 
Heimberg  &  Kraemer,  1992;  Hale,  1998;  Rubinow  &  Post,  1992),  Obsessive 
Compulsive  Disorder  (OCD)  (Sprengelmeyer,  Young,  Pundt,  Sprengelmeyer, 
Calder,  Berrios,  et  al.,  1997),  psychopathy  (Blair,  Colledge,  Murray  &  Mitchell, 
2001;  Kosson,  Suchy,  Mayer  &  Libby,  2002)  and  acquired  sociopathy  (Blair  & 
Cipolotti 2000; Homak, Rolls & Wade,  1996).
61FER  has  also  been  investigated  in  several  drug  and  alcohol  using  populations. 
Chronic  alcohol  use has  been  associated  with both poor FER  (Komreich,  Blairy, 
Philippot,  Dan,  Foisy,  Le  Bon,  et  al.,  2001a)  and  interpersonal  difficulties 
(Komreich,  Philippot,  Foisy,  Blairy,  Raynaud,  Dan,  et  al.,  2002).  Philippot, 
Komreich,  Blaiiy, Baert,  Den Dulk, Le Bon,  et al.  (1999)  found impaired FER in 
recently detoxified alcoholics, with significant deficits in recognising anger, sadness, 
happiness  and  disgust  and  a  special  bias  towards  over-attribution  of anger  and 
contempt.  Research with ecstasy users is still in its infancy, however Hoshi,  Bisla 
and Curran  (2004)  found that ecstasy impacted on FER,  enhancing recognition of 
fearful  expressions  following  acute  administration  and  impairing this  ability  four 
days later. Hoshi et al. also used a measure of aggression at these two time points, 
with the finding that users had higher self rated aggression scores than controls at 
day  4,  despite  there  being no  difference  in  this  rating  on  the  night  of drug use. 
Benzodiazepines have been seen to selectively impair the recognition of anger (Blair 
& Curran,  1999) and fear (Zangara, Blair & Curran, 2002). While benzodiazepines 
are used for their anxiolytic properties, they have been noted to have  ‘paradoxical’ 
side-effects  such  as  disinhibition,  hostility  and  aggression  (Bond,  Curran,  Bmce, 
O’Sullivan & Shine, 1995; Zangara et al., 2002).
One  major class  of dmgs  which  is  underrepresented  in  the  literature  on  emotion 
processing is that of opiates. Morphine, codeine, heroin and methadone are all forms 
of opiate that are widely used for pain relief, as dmgs of abuse or as treatment for 
drug abuse. The prevalence of opiate use is difficult to gauge as it is a largely hidden 
problem. However, a recent estimation suggested a prevalence of 3.7% among men 
aged  25-44  in  London  (Hickman,  Higgins,  Hope  &  Beilis,  2004).  Every  year,
62community pharmacies across England dispense over 1.25 million NHS prescriptions 
for methadone, suggesting that about 50,000 opiate users are receiving methadone at 
any one time (Strang & Sheridan, 2003). There is now substantial evidence for the 
effectiveness  of methadone  maintenance  treatment  (National  Treatment  Agency, 
2004) for opiate users. Methadone treatment is also associated with  improvements in 
health and social functioning,  lower levels of crime and a lower risk of premature 
mortality  (National  Treatment  Agency,  2004).  Despite  such  high  levels  of use, 
relatively little is known about the effects of this class of drug upon psychological 
functioning.
It  is  of  note  that  heroin  use  almost  never  occurs  in  isolation,  with  cocaine, 
amphetamines and benzodiazepines also being widely used by drug misusers seeking 
treatment for heroin dependence (Gossop, 2005). The National Treatment Outcomes 
Research  Study (Gossop,  Marsden,  Stewart,  Lehmann,  Edwards,  Wilson &  Segar, 
1998) found that almost two thirds of drug users in treatment had been using three or 
more  substances before admission to treatment,  and more than a third were using 
stimulants  on  a  frequent  basis.  The  most  commonly  used  stimulant  among  drug 
misusers seeking treatment for heroin dependence was crack cocaine (Gossop, 2005).
Most  opiate users  seeking treatment present with a range of difficulties  including 
severe family and social problems (National Treatment Agency, 2004). Personality 
disorder is commonly found in heroin users, with prevalence figures of around 50%, 
in which borderline,  antisocial and dependent types are over-represented (Fassino, 
Daga, Delsedime, Rogna & Goggio, 2004). A dimensional approach has also been
63taken to  identify specific personality traits of heroin users,  with Khantzian (1997) 
suggesting that heroin users are “immature and unable to take care of themselves”. 
Other studies propose that users have poor self-esteem (Fieldman, Woolfolk & Allen, 
1995),  unstable  personal  relationships  and  identities  (Fassino,  Scarso,  Barbero, 
Taylor, Pezzini & Furlan,  1992), as well as poorly regulated emotions and impulse 
control  (Bartholomew,  Sher  &  Wood,  2000;  Conway,  Kane,  Ball,  Poling  & 
Rounsaville, 2003).
The literature thus suggests that not only is FER impaired in many populations that 
are characterised by poor social behaviour, but also that the specific nature of the 
FER impairment may be connected to the type of social functioning deficit. Given 
the  interpersonal  difficulties  encountered  by  opiate  users,  in  addition  to  the 
pharmacological  changes  that  are  brought  about by opiate  use,  it  is  possible  that 
accuracy and/or speed of FER is affected in this population.
Opiate receptors are widely distributed throughout the brain, being particularly dense 
in the amygdala (involved in emotional processing), nucleus accumbens (important 
in opiate reward) as well as areas concerned with pain perception.
The only published study in this area is by Komreich, Foisy, Philippot, Tecco, Noel, 
Hess, et al. (2003), who compared FER in five groups of participants:  1) methadone 
maintained  opiate  users,  2)  recently  detoxified  alcoholics,  3)  recently  detoxified 
alcohol and opiate users 4) recently detoxified opiate users, 5) normal controls. They 
found that the recently detoxified alcoholic group and mixed detoxified alcohol and 
opiate  group  scored significantly lower on accuracy of FER than normal controls.
64The  methadone  maintained  group  and  recently  detoxified  opiate  group  accuracy 
scores were comparable and better than those of the mixed detoxified alcohol and 
opiate group and detoxified alcohol only group, but worse than the normal controls. 
Unfortunately  this  study  did  not  differentiate  between  the  individual  emotional 
expressions.  The  authors  also  found  that  the  length  of abstinence  in  the  opiate 
abstinent  group  did  not  influence  FER  scores.  This  could  be  taken to  mean that 
opiates do not have a detrimental effect on FER and that pre-existing deficits account 
for the lower scores than normal controls, or that the impairments caused by opiate 
use  persist  long  after  discontinuation,  as  was  found  with  alcoholic  subjects 
(Komreich, Blairy, Philippot, Hess, Noel, Streel, et al., 2001b).
No study has yet looked at the effect of opiates on the recognition of individual facial 
expressions.  This  study investigated accuracy and  speed of FER in current opiate 
users, abstinent ex-users and healthy controls. Male samples were used to minimise 
variation  due  to  gender  differences  in  FER  ability  (Hall,  1984;  Hoffman,  1977). 
Demographic variables such as age, IQ, years of education, alcohol use and years of 
exposure  to  different  dmgs  were  recorded  in  order  to  measure  comparability  of 
groups.  If the  groups  differed  significantly on these  variables,  they were used  as 
covariates  in  the  analyses.  Self  report  measures  of  impulsivity,  aggression  and 
socialisation were also used in order to  compare the profiles of the groups.  These 
particular constructs were selected on the basis of the literature regarding defining 
personality characteristics  of opiate users.  A mood measure  was used  in order to 
investigate any correlation with recognition of particular expressions as suggested in 
the literature. On the basis of Komreich et al.’s (2003) findings, it was hypothesised 
that both the methadone maintained and detoxified opiate using groups would show
65impaired FER relative to normal controls. Given the lack of existing data regarding 
individual facial expressions, this aspect of the study was exploratory. It was hoped 
that  group  numbers  would be  sufficient  for some  exploratory  sub-group  analysis, 
comparing crack and non-crack using participants, as well as perpetrators and non­
perpetrators of violent crime, on both demographic measures and the faces task.
A power calculation was carried out using group differences obtained on the same 
version of the faces task in Blair and Curran’s (1999) study investigating the effects 
of diazepam on recognition of angry expressions. With an alpha value of 0.05 and 
power of 0.8, the suggested sample size was 20 participants per group.
Materials and Method
Design and Participants
An independent groups design was used to compare current methadone users (MM) 
with  ex-opiate  users  in  rehabilitation  (R)  and  healthy  controls  (C).  MMs  were 
recruited from a substance misuse clinic where they were receiving daily methadone 
maintenance treatment.  Participants were identified as potentially suitable by their 
key worker.  Rs  were recruited  from three  drug rehabilitation programmes,  two  of 
which  were  residential  and  one  a  day  programme.  All  R  participants  had  been 
abstinent from opiates for at least six weeks and they had an mean time since last 
using opiates of 23.7 (±19.8) weeks. The healthy controls were recruited from a local 
Job Centre. Control participants were screened for both current and past problematic 
substance use,  using the Cut-down Annoyed Guilty Eye-opener Scale:  Adapted to 
Include  Drugs  (CAGE-AID;  Brown  &  Rounds,  1995).  Individuals  with  current
66diagnosed mental health problems such as depression, schizophrenia and significant 
anxiety were excluded from the study in all three groups. The study was approved by 
the institutional ethics committee and all participants gave written informed consent.
Procedure
Potential  MM  and  R  participants  were  given  an  information  sheet  by  their  key 
worker  and  time  to  consider  the  study.  If  interested,  they  were  then  taken 
individually to the testing room where the study was explained more fully and they 
were given the opportunity to ask questions. If they were willing to participate they 
were asked for written consent. They then completed the assessments detailed below. 
At the end of testing they provided a urine sample which was tested for methadone 
and  a  range  of illicit  drugs.  They  received  payment  in  the  form  of supermarket 
vouchers. Testing was conducted on site (i.e. at the substance misuse clinic for MMs, 
and at the different rehab centres for Rs).
Control subjects were recruited and tested in a quiet room on site at the Job Centre. 
They were approached while waiting to see Job Centre staff, given an information 
sheet, after which they were given time to consider the study and ask questions. If 
willing to participate, they were then asked for written consent, following which they 
completed the  assessments  detailed below.  At the  end  of testing they were  given 
payment  in  the  form  of supermarket vouchers.  Urine  samples  were  not collected 
from the control group.
67Questionnaire Measures
Trait Measures andpre-morbid IQ
The  Aggression  Questionnaire  (AQ;  Buss  & Perry,  1992)  was used to  index  trait 
aggression,  and  the  Barratt  Impulsivity  Scale  (BIS;  Barratt,  1994)  was  used  as  a 
measure of trait impulsivity. The Gough Socialisation Scale (Gough, 1960) was used 
as a measure of the extent to which societal values are internalised (high scores being 
indicative of socialised behaviour).  This scale correlates with antisocial behaviour. 
The  ‘Spot the Word’  test (Baddeley,  Emslie & Nimmo-Smith,  1993)  was used to 
index  pre-morbid  IQ  as  this  measure  correlates  highly  with  the  National  Adult 
Reading Test (NART; Nelson & Willison, 1978).
Mood state and alcohol use
The  Depression  Anxiety  Stress  Scale  (DASS;  Lovibond  &  Lovibond,  1995)  was 
used  to  assess  participants’  levels  of anxiety,  depression and  stress  over the  past 
week.  Alcohol  use  was  assessed  using  the  Fast  Alcohol  Screening  Test  (FAST; 
Hodgson, John, Abbasi, Hodgson, Waller, Thom & Newcombe, 2002). This measure 
gives an indication of hazardous alcohol use.
Drug use history
Frequency and quantity of illicit drug and alcohol use, both historically and in the 30 
days prior to testing was recorded. Number of opiate overdoses and history of head 
injury was also noted.
68Recognition of Facial Expressions
This  task used the  stimuli  from  the Facial  Expressions  of Emotions:  Stimuli  and 
Tests  (FEEST;  Young,  Perrett,  Calder,  Sprengelmeyer  &  Ekman,  2002).  Thirty 
stimuli  were presented,  featuring a male  face portraying the  six basic  emotions - 
happiness, surprise, sadness, fear, disgust and anger -  from the Ekman (1976) series. 
These basic emotions were used to create stimuli that are morphed from one emotion 
to another in 5  stages (10%, 30%, 50%,  70%, 90%). The expressions morphed are: 
anger to happiness, happiness to surprise, surprise to fear, fear to sadness, sadness to 
disgust and disgust back to anger. All stimuli involved the face JJ (Ekman & Friesen, 
1976).
The task was performed on a laptop computer and consisted of 6 presentation blocks. 
In each block, the 30 morphed stimuli were presented in pseudo-random order (i.e. 
constraints  were  in place  to  ensure  that no  more  than two  stimuli with the  same 
majority expression appeared consecutively). Each stimulus appeared on the screen 
for 500ms. The task was specially programmed with a response facility whereby the 
6 emotions were arranged in an equilateral hexagon in the centre of the right side of 
the screen, next to the faces which were presented on the left hand side of the screen. 
Each emotion was equidistant from the central cursor base. Participants were asked 
to choose the emotion that corresponded to the facial  expression by clicking on it 
with the mouse,  as  quickly and as accurately as they could.  This response facility 
was  designed to  both  lessen the  working memory  load  required to  remember six 
different  response  keys  and to  ensure that the response  to  each emotion required 
equal  motor  movement.  Both  response  and  reaction  time  were  automatically 
recorded, and the recognition accuracy and reaction time scores that were used in the
69analysis were calculated from the correct responses to the stimuli that had a dominant 
percentage (90% or 70%) of each emotion (see Hoshi et al., 2004 for details).
Other Information
At  the  end  of  testing,  each  participant  was  asked  whether  they  had  personal 
experience of being either a victim or perpetrator of violent crime.
Statistical Analysis
3 x 6   repeated  measures  ANOVAs  were  used  to  analyse  the  facial  expression 
recognition  task  accuracy  and  response  time  scores,  with  group  (methadone 
maintained (MM), ex-opiate users in rehabilitation (R) and control (C)) as a between 
subjects factor and expression (happiness, surprise, fear, sadness, disgust, anger) as a 
within subjects factor. Greenhouse-Geisser corrections were used where appropriate. 
Because of the group differences that emerged with years of education, this variable 
was used as a covariate in these analyses. One-way ANOVAs and t-tests were used 
to  compare  the  groups’  demographic  and  questionnaire  data.  Simple  effects 
(Bonferroni  corrected)  post-hoc  analysis  was  conducted  on  variables  showing 
significant  group  differences.  Bivariate  correlations  (Pearsons)  were  performed 
within  the  MM  and  R  groups  to  analyse  relationships  between  demographic 
information,  questionnaire  measures  (total  scores  only)  and  the  faces  task. 
Independent sample t-tests were used in exploratory analyses of differences between 
the  following  subgroups:  crack-using  and  non  crack-using  MM  participants, 
perpetrators of violent crime and those who had not committed violent crime.
All data were analysed using SPSS for Windows version 11.5.
70Results
Demographics
There were no significant group differences in age or Spot-the-Word scores (Table 
1). The groups differed in years of education (F2,58 = 9.36, p<0.001) with controls (C) 
having longer than methadone maintained (MM) (p=0.007) and ex-opiate users (R) 
(pO.OOl).  The  groups  scored  comparably  on  the  FAST  suggesting  no  group 
differences in problematic alcohol use over the past year. MM had first used heroin 
at a  significantly younger age than R (t3g= -2.406, p=0.021) and had subsequently 
used  for  significantly  more  years  (t38=2.172,  p=0.036).  Both  R  and  MM  had 
comparable self-reported years of exposure to crack cocaine and alcohol.
The methadone maintained  (MM)  group  consisted  of 20  male  participants,  19  of 
whom were taking daily methadone, and  1   Subutex as part of substitute prescribing 
treatment.  The  vast  majority  of  the  group  had  a  long  and  chaotic  history  of 
polysubstance  abuse,  including alcohol,  benzodiazepines,  crack,  cocaine,  cannabis 
and  amphetamines.  However,  at  the  time  of  testing  none  was  using  crack  or 
benzodiazepines more than twice per week, and none had significantly problematic 
alcohol use, as defined by their keyworker.  85% (n=17) classified their ethnicity as 
white British, while 15% (n=3) were made up of Affo-Caribbean and Other.
The  ex-opiate  user  (R)  group  consisted  of  twenty  male  participants  who  were 
attending drug rehabilitation programmes; 4 attended a day programme only, while 
the remaining  16 were in residential treatment.  All participants had been abstinent
71from opiates for at least 6 weeks, with an average time since last use of 23.7 (19.8) 
weeks. Similar to the MM group, the vast majority of this group also had a long and 
chaotic  history of polysubstance  abuse,  but all  identified  opiates  as  their primary 
problematic substance. 80% (n=16) classified their ethnicity as White British and the 
remaining 20% (n=4) were Afro-Caribbean, Black British and American.
The  control  group  consisted  of 21  unemployed  males,  none  of whom  had  used 
opiates  in  the  past  30  days,  nor  had  a  significant  history  of  opiate  use.  Two 
participants had tried heroin once, and one had used heroin twice over 2 months. In 
the 30 days prior to testing, 2 participants had used cocaine, 9 used cannabis and 1  
used ecstasy. This was deemed to be recreational use that did not meet the threshold 
for problematic  substance use,  as assessed by the CAGE-AID  (Brown &  Rounds, 
1995).  Twenty participants had used alcohol in the 30 days prior to testing,  and  1  
defined  his  alcohol  use  as  problematic  for 2  years,  2  years prior to  testing.  57% 
(n=12) of this group classified themselves as White British, with 19% (n=4) Irish and 
the remaining 24% coming from Afro-Caribbean, Black British,  British Asian and 
Other ethnic backgrounds.
Current substance use in clinical groups 
MM group
In the 30 days prior to testing, 13 participants reported having used cannabis,  11 used 
heroin, 11 used alcohol, 8 used crack, 5 used benzodiazepines, 2 used cocaine, 1  used 
amphetamines and 18 smoked tobacco. This additional drug use varied in frequency 
from once to  every day during the 30-day period.  Urine  screening was  conducted 
with 18/20 participants. Methadone was detected in the urine of 17/18 participants
72Table 1: Group mean scores (and standard deviations) for demographic information
(different subscripts indicate significantly different means).
Group
Methadone  Maintained 
(MM)
Rehab
(R)
Control
(C)
N 20 20 21
Age 38.40 (4.57), 37.55 (9.11), 35.81 (6.82),
Years of education 11.7(2.08), 10.85 (2.43), 14.62 (3.91) b
% unemployed 85%, 100%, 100%,
Spot the word score 49.10(4.88), 48.00 (5.33), 50.24 (4.16),
Methadone dose mgs (prior to 
detox for R group)
64.95 (26.05), 60.71 (23.03),
Number of opiate overdoses 1.0(1.37), 1.3 (2.13),
Age heroin first used 19.70 (5.98), 25.61 (9.25) b
Years of exposure to heroin 14.08 (6.58), 10.50 (7.42) b ’
Years  of  exposure  to  crack 
cocaine
5.9 (7.32), 5.75 (5.00),
„   Is  f\
m m M tW
Years of exposure to alcohol 19.5 (9.08), 19.75 (11.83), 17.57 (6.71),
FAST score 3.05 (4.32), 4.10(5.70), 2.14(1.82),
N meeting threshold for 
hazardous alcohol use 
in past year (FAST>/=3)
7a 9, 8,
DASS total score 20.9 (15.66), 23.30(11.54), 8.05 (7.86) b
Anxiety score 7.55 (5.68), 7.80 (5.13), 2.62 (2.58) b
Depression score 5.35 (5.37), 5.75 (4.18), 1.00 (1.82) b
Stress score 8.00 (5.26), 9.75 (3.86), 4.48 (4.33) b
BIS total score 75.7 (13.46), 77.35 (9.70), 66.95 (10.39) b
Non-planning score 32.5(5.91), 32.65 (3.94), 28.33 (4.74) b
Motor score 23.2 (5.44), 23.65 (5.0), 20.71  (3.44),
Attentional score 20 (4.92), 21.05 (3.33), 16.48 (3.84) b
Gough score 24.7 (7.4), 22.95 (6.71), 31.9 (5.9) b
AQ total score 79.6 (24.12),,b 91.7 (20.48), 69.81 (15.81) b
Physical aggression score 24.75 (8.94U 29.45 (8.53), 19.86 (4.86) b
Verbal aggression score 15.9 (3.28), 16.15(4.3), 15.38 (4.26),
Anger score 18.65 (6.43),,b 22.05 (5.39), 15.81  (4.8) b
Hostility score 20.6 (7.73),,b 24.05 (7.61), 18.33 (6.4) b
Guilt score 26.15 (6.95), 31.55 (6) b 23.1  (7.48),
73(the  18th  participant  was  taking  Subutex),  non-methadone  opiates  in  5/18 
participants,  benzodiazepines  in  4/18,  cocaine  (including  crack)  in  5/18,  and 
amphetamines  in  no  participants.  Self-reported  drug  use  corresponded  to  that 
indicated by urine screening.
R Group
All participants reported abstinence from other drugs and alcohol for at least 30 days, 
with the exception of 1   participant who had used cannabis once, and 2 participants 
who  had  used  alcohol  once.  Urine  screening  was  conducted  with  17/20 
participants,detecting cannabis in one participant. The remainder of the screens were 
clear for all drugs tested.
Questionnaire Measures  (Table 1)
DASS:
Group differences (F2,58=9.55, p<0.001) reflected lower scores of controls than MM 
(p=0.004) and R (p<0.001) on DASS total score. This was also the case for each of 
the  subscales:  anxiety  (F2,58=8 .2 1 ,  p=0.001),  depression  (F2,58=8.79,  p<0.001)  and 
stress (F2,58=7.27, p=0.002).  Controls had lower scores than both MM (depression: 
p=0.003;  anxiety:  p=0.004;  stress:  p=0.046)  and R  (depression:  p=0.001;  anxiety: 
p=0.002; stress: p=0.001). There were no differences between the MM and R group 
on any DASS score.
Barratt Impulsivity Scale:
Group differences (F2,58=5 .0 6, p=0.009) reflected lower scores of Controls than MM 
(p=0.048)  and R (p=0.014)  on the BIS  total score.  This was also the case  for the 
following  subscales:  non-planning  impulsivity  subscale  (F2,58=5.11,  p=0.009),
74attentional  impulsivity subscale  score (F2,58=7.11, p=0.002)  .  There were no  group 
differences  on  the  motor  impulsivity  subscale  score.  The  MM  and  rehab  group 
scored comparably on all aspects of the Barratt Impulsivity Scale.
Gough Socialisation Scale:
Group  differences  (F2,58=10.41,  p<0.001)  reflected  higher  scores  of controls  than 
MM (p=0.003) and R (p<0.001). MM and R scored comparably on the Gough scale. 
Aggression Questionnaire:
Group differences  (F2,58=5.94, p=0.005) reflected higher scores of R than Controls 
(p=0.003) on AQ total score. There were no significant differences between MM and 
R group, or the MM and Controls on total AQ score. Group differences on subscales 
measuring physical aggression (F2,58=8.11, p=0.001), anger (F2,58=6.45, p=0.003) and 
hostility (F2,58=3.22,  p=0.47)  reflected higher scores  of R than controls  (p<0.001, 
p=0.002  and  p=0.043  respectively).  All  groups  scored  comparably  on  the  verbal 
aggression subscale.  Group differences on the guilt subscale (F2,58=7.97, p=0.001) 
reflected higher scores of R than both MM (p=0.047) and controls (p=0.001).
Facial expression task 
Accuracy scores
Repeated  measures  ANOVA  showed  a  significant  expression  x  group  interaction 
(F10,108=2.04,  p=0.036),  and  a  main  effect  of expression  (Fs,54=  79.53,  p<0.001). 
Years of education was not a significant covariate. Given this interaction, one-way 
ANOVAs  were  conducted on  each  separate  emotion and group,  using Bonferroni 
corrected post-hoc analysis.
75There was a significant group difference in identifying disgust (F2,58=3.72, p=0.03), 
reflecting higher accuracy scores of MM than R (p=0.033) (see Figure 1  (Table 2)). 
Covariance of years of education did not affect this finding. Additionally, ANOVA 
suggested a trend regarding group differences in the identification of sad expressions 
(F2,58=3.083, p=0.053). However, this was no longer significant after covarying years 
of education (p=0.23).
Table 2: Mean scores (and standard deviations) on facial expression task
(different subscripts indicate significantly different means).
Group
Methadone Maintained Rehab Control
Accuracy scores Happy 22.95(1.28), 22.70(1.84), 23.10(2.17),
Surprise 21.00 (2.55), 19.55 (3.03), 19.52 (3.43),
Fear 12.55 (4.3), 11.55 (6.83)a 14.90 (4.29),
Sad 15.90 (2.47),,b 14.55 (4.67) a 17.52 (4.03)b
Disgust 17.60 (4.65) a 11.95 (7.63) b 13.43 (7.63)a,b
Anger 14.70 (5.7)a 14.25 (5.5), 13.29 (6.37),
Reaction  times 
(msecs)
Happy 2571.33 (500.58) a 2030.59 (431.39) b 1736.64 (384.59)b
Surprise 3131.84 (675.42)a 2672.60 (498.53) c 2237.16 (508.55) b
Fear 3429.44 (844.96) a 2491.90 (1203.17)b 2151.25 (509.13) b
Sad 4006.70 (1076.61) a 3493.72(1053.65) a 2457.02 (722.03) b
Disgust 3468.98 (879.71) a 2846.12(1075.36) a,b 2587.70 (719.38)b
Anger 3221.82 (862.1) a 2842.00 (1015.51)a,b 2356.89 (680.95) b
Reaction Times
There was no group x  expression interaction,  but a significant main effect of both 
group  (F2,  58=16.76,  pO.OOl)  and  expression  (F5,54=30.51,  p<0.001).  Covarying 
years of education did not change the significance of group differences (p<0.001), 
however there was no longer a main effect of expression. Covariance showed a trend
76towards  an  expression  x  group  interaction  (p=0.089).  Subsequently,  one-way 
ANOVAs were conducted on each separate emotion and between groups on overall 
reaction time for the task, using Bonferroni corrected post-hoc analysis.
Across all expressions, the control group showed the fastest reaction times followed 
by the rehab group, with the MM group having the slowest reaction times (Figure 2 
(Table  1)).  Overall  group  reaction  times  were  significantly  different:  MM-R: 
p=0.008, MM-C: p<0.001, R-C: p=0.034. There were significant differences between 
the groups on all 6  expressions (happy,  surprise,  fear and sad p<0.001,  disgust p= 
0.009  and  anger p=  0.008).  Covariance  of years  of education  did  not  affect  this 
pattern of results.  Post-hoc  analysis  showed that the  MM  group  was  significantly 
slower on all expressions than the Control group (p<0.001  for happy,  surprise, fear 
and  sadness;  p=0.008  for disgust and p= 0.006  for anger).  The Rehab  group was 
significantly slower than the Control group on expressions of surprise (p= 0.05) and 
sadness (p= 0.003). The Rehab group were significantly faster than the MM group in 
responding to expressions of happiness (p= 0.001), surprise (p= 0.039) and fear (p= 
0.005).
Correlations 
MM group
The  only  correlation with  the  faces  task  was  found  between  BIS  total  score  and 
accuracy of fear recognition (r= -0.529,  p= 0.016).  Age  at which heroin was  first 
used  correlated  negatively with total  DASS  score  (r=  -0.511,  p=0.021),  total  BIS 
score (r= -0.548, p= 0.012), total AQ score (r= -0.491, p= 0.028), and positively with
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78Gough score (r= 0.673, p= 0.001). Years of exposure to heroin correlated negatively 
with Gough score (r= -0.529, p=0.017).
Rehab group
The  dose  of methadone  taken  prior  to  entering  rehab  correlated  positively  with 
disgust recognition accuracy (r= 0.612, p= 0.02).
Subgroup analysis
i)  Perpetrators  (n=8)  and non-perpetrators  (n— 12)  of violent crime in MM group 
Perpetrators of violent crime scored higher than non-perpetrators on the DASS (ts.53= 
2.64, p= 0.028), BIS (ti0.52= 2.23, p= 0.049) and AQ (ti8= 4.42, p<0.001) (Table 3). 
They  scored  lower  on  the  Gough  than  non-perpetrators  (tj8=  -5.41,  p<0.001). 
Perpetrators  of violent  crime  had  slower  reaction  times  to  facial  expressions  of 
happiness than non-perpetrators (ti8= 3.25, p= 0.004).
Table 3: Mean scores (and standard deviations) for perpetrators and non-perpetrators 
of violent crime in the MM group.
Perpetrators (n=8) Non-perpetrators (n=12)
DASS total score 31.88 (18.66) 13.58(7.5)
BIS total score 83.75 (15.23) 70.33 (9.33)
AQ total score 100.38 (20.35) 65.75 (14.78)
Gough score 17.75 (4.2) 29.33 (4.98)
Reaction time -  Happiness 2934.55 (579.43) 2329.19 (243.45)
79ii)  Perpetrators (n— 13) and non-perpetrators (n-7) of violent crime in R group 
Perpetrators of violent crime had lower spot-the-word scores than non-perpetrators 
(tig= -2.9, p=0.009) (Table 4). Perpetrators of violent crime tended to score higher on 
the AQ (ti8= 1.99, p=0.062) than non-perpetrators. Perpetrators of violent crime had 
less accurate recognition of anger than non-perpetrators (tis= -2.32, p= 0.032).
Table 4: Mean scores (and standard deviations) for perpetrators and non-perpetrators 
of violent crime in the R group.
Perpetrators (n=13) Non-perpetrators (n=7)
Spot-the-word score 45.85 (5.05) 52 (3.22)
AQ score 97.92 (20.12) 80.14(16.71)
Accuracy score -  Anger 12.62 (5.91) 17.29 (3.1)
Hi) Crack (n=14) and non-crack users (n=6) in MM group
Crack users had less accurate recognition of disgust (tis= -2.72, p=0.014) and anger 
(ti8=  -2.91,  p=0.009)  than non-crack users  (Table  5).  There  was  a  trend  towards 
crack-users reporting more impulsivity than non-crack users (ti8=1.996, p=O.061).
Table 5: Mean scores (and standard deviations) for crack and non-crack users in the 
MM group.
Crack users (n=14) Non-crack users (n=6)
Accuracy score - Disgust 16.00 (4.57) 21.33 (1.97)
Accuracy score - Anger 12.64 (5.33) 19.50 (3.21)
BIS total score 79.36 (14.57) 67.17 (3.43)
80Discussion
Profile of Groups
The  clinical  groups  (i.e.  MM  and  R)  experienced  more  symptoms  of depression, 
anxiety and  stress  (DASS),  reported more  impulsivity (BIS)  and  a  lower level  of 
socialisation (Gough) than the Control group. R reported more aggression (AQ) than 
controls  and  MM,  but  only  the  R-C  difference  was  significant.  Correlations 
suggested  that  within  MM,  the  earlier  participants  had  started  using  opiates,  the 
higher  the  levels  of  self-reported  depression,  anxiety,  stress,  impulsivity  and 
aggression were, and the lower the levels of socialisation.  It is unsurprising that the 
clinical  groups  reported  more  symptoms  of  depression,  anxiety  and  stress  than 
controls,  given that drug use often acts as an avoidant coping strategy for difficult 
feelings (LeBon, 2004). Similarly, the literature supports the finding that opiate users 
are more impulsive (Franques, Auriacombe & Tignol, 2000), antisocial (Fassino et 
al.,  2004)  and  aggressive  (Gerra,  Amir,  Raggi,  Giusti,  Delsignore,  Bertacca  & 
Brambilla,  2001)  in  personality  than  controls.  It  should  be  noted  that  with  no 
additional  objective  measures  of  aggression,  impulsivity  or  socialisation  to 
corroborate  the  self report  of participants,  these  profiles  should  be  treated  with 
caution, as self report is based on individual judgement and therefore open to bias.
Main research question and findings
On the basis of Komreich et al.’s (2003) findings, it was hypothesised that both MM 
and R would show impaired FER on the faces task relative to controls. Investigation 
of individual facial expressions was exploratory due to the lack of existing literature.
81Firstly,  in  accord  with  other  studies  of FER  (e.g.  Leppanen  &  Hietanen,  2003; 
Rapcsak,  Galper,  Comer,  Reminger,  Nielsen,  Kaszniak,  et  al.,  2000),  this  study 
showed happiness to be the easiest emotion to recognise, with accuracy scores near 
ceiling,  the  fastest  reaction  times  and  no  group  differences.  The  more  difficult 
emotions to recognise were fear, disgust, sadness and anger.
The results of the faces task showed a clear group hierarchy in reaction times; the 
reaction times of MM were the slowest across all expressions, followed by R, with 
the  controls  responding  fastest.  This  reached  significance  on  some  but  not  all 
expressions.  This could reflect the effects of opiates on processing speed (Verdejo, 
Toribio,  Orozco,  Puente  &  Perez-Garcia,  2005),  psychomotor  speed  (Hiltunen, 
Lafolie, Martel, Ottosson, Boreus, Beck, et al., 1995; Mintzer & Stitzer, 2002) and/or 
decision making (Mintzer &  Stitzer,  2002),  which research indicates may start to 
remit with abstinence (Davis, Liddiard & McMillan, 2002; Verdejo et al., 2005).
However,  in  terms  of accuracy  there  was  no  such  clear  hierarchy.  MM  did  not 
display any  significant deficits  in recognition  accuracy.  The  most notable  finding 
was  the  group  difference  in  recognition  of disgust,  with  MM  showing  enhanced 
recognition of disgust over R (and non-significantly over controls).  Moreover, the 
absence of a difference between the reaction times of the two groups to expressions 
of  disgust  suggests  that  a  speed/accuracy  trade-off  does  not  account  for  this 
improved accuracy.  Within R, dose of methadone prior to detoxing was correlated 
with accuracy of disgust recognition. Within MQvl, participants’ poorer recognition of 
fear was associated with increased impulsivity.
82The current findings do not support those of Komreich et al. (2003). Komreich et al. 
found globally impaired FER in both methadone maintenance treatment (MMT) and 
detoxified opiate addicts (DOA) compared with healthy controls.  The opiate using 
samples  in  Komreich  et  al.’s  study  had  a  similar history  of polydrug use  to  the 
samples in the current study but a shorter history of using opiates (MMT=9.32 years 
vs  MM=14.08  years,  DOA=7.8  years  vs  R=10.50)  and  lower  average  age 
(MMT=31.53  years  vs  MM=38.4  years,  DOA=28.93  years  vs  R=37.55  years). 
Komreich  et al.  also  excluded participants  on the basis  of current or past alcohol 
dependence. While current problematic alcohol use was an exclusion criteria for MM 
in the current study, past alcohol dependence was not screened out, in either MM or 
R.  These  differences  in  the  samples  are  unlikely  to  account  for  the  discrepant 
findings  as  greater  exposure  to  opiates  and  alcohol  would  seem  more  likely  to 
increase FER impairments.
So how do we explain the finding that MM show hypersensitivity to expressions of 
disgust?  Psychiatric  and  drug-using  populations  in  which  impaired  disgust 
recognition  has  been  found  include  OCD  patients  (Sprengelmeyer  et  al.,  1997), 
psychopaths  (Kosson et al.,  2002)  and detoxified alcoholics (Townshend & Duka, 
2003). Impaired disgust recognition has also been seen in schizophrenia (e.g. Kohler 
et al., 2003), although as only one of several impaired expressions, suggesting a more 
global deficit.
The  case  of OCD  and  disgust  recognition  is  particularly  interesting.  It  has  been 
suggested that  abnormal  experience  of disgust may be  involved  in the  genesis  of 
obsessions and compulsions (Power & Dalgleish,  1997), as so many OCD patients
83exhibit heightened disgust in reaction to stimuli they regard as contaminated (Parker, 
McNally,  Nakayama  &  Wilhelm,  2004).  Additionally,  evidence  suggests  that 
abnormalities  exist  in the  basal  ganglia  of obsessive-compulsive  disorder patients 
(Parker et al., 2004). However, the research evidence regarding FER is contradictory. 
One  study has  found  selectively impaired  recognition of disgust  in OCD  patients 
(and  Tourette’s  syndrome  patients  with  obsessive-compulsive  features 
(Sprengelmeyer et al.,  1997),  while three others have  failed to replicate this result 
(Buhlmann, McNally,  Etcoff,  Tuschen-Caffier & Wilhelm,  2004;  Komreich et al., 
2001a; Parker et al., 2004). Parker et al. (2004) conclude that impairments in disgust 
recognition may only occur in cases of severe OCD. A further study by Montagne, 
Kessels,  de Geus, Denys,  de Haan & Westenberg (2005)  found that OCD patients 
were more sensitive to all emotional expressions than healthy controls, but failed to 
find a disgust-specific effect in the group as a whole. Additionally, in contrast with 
Sprengelmeyer et al. and Parker et al., their results showed that those OCD patients 
with more severe symptomatology demonstrated more accurate disgust recognition 
than controls.
Specific  impairment  of disgust  recognition  has  also  been  found  in  psychopaths 
(Kosson et al., 2002). It has been proposed that psychopaths have a limited capacity 
for understanding and experiencing emotion (Blair,  Colledge,  Murray & Mitchell, 
2001), and unlike non-psychopaths, they also fail to exhibit startle potentiation while 
viewing slides depicting mutilation (Levenston, Patrick, Bradley & Lang, 2000). If, 
as has been  suggested,  disgust is important in negative  socialisation,  longstanding 
insensitivity to other’s disgust could conceivably contribute to the poorly socialised 
behaviour seen in the psychopathic population.
84Although detoxified alcoholics have also been found to show a disgust recognition 
deficit  (e.g.  Philippot,  Komreich,  Blairy,  Baert,  Den  Dulk,  Le  Bon,  et  al.,  1999; 
Townshend & Duka, 2003), this is often seen alongside deficits with other emotions, 
in particular anger. Such individuals have been seen to frequently misidentify disgust 
as anger (Townshend & Duka, 2003), suggesting an attributional bias which may be 
associated with the interpersonal difficulties seen in this population (Komreich et al., 
2002).
To  date,  only  one  other  study  has  found  enhanced  disgust  recognition  in  any 
population.  In  studying  euthymic  bipolar disorder patients,  Harmer,  Grayson  and 
Goodwin  (2002b)  found  generally  impaired  FER  performance,  but  enhanced 
recognition  of disgust  and  fewer  false  positive  disgust  expression  identifications, 
compared with  controls.  The  authors  discuss  the  impact  of mood  disorder on the 
basal ganglia,  in particular the caudate. Neuroimaging studies suggest that caudate 
volume may be increased in bipolar patients relative to matched controls (Aylward, 
Roberts-Twillie,  Barta,  Kumr,  Harris,  Geer,  et al.,  1995),  in addition to  increased 
levels of neural activity within the caudate during periods of acute mania (Blumberg, 
Stem, Martinez, Ricketts, de Asis, White, et al., 2000). They also consider whether 
more  accurate  recognition  of disgust  could  be  associated  with  the  negative  self­
perception that has been found in bipolar patients (Lyon, Startup & Bentall, 1999), in 
particular low self-esteem and increased anxiety. However, they do not elucidate the 
mechanism by which this could happen.
85Evidence from the populations reviewed begins to indicate that the story surrounding 
disgust  is  far from  straightforward.  It may prove  helpful  to  think more  about the 
function of disgust and how this could relate to opiate users.  It has been proposed 
that the emotion of disgust is based on the appraisal of objects and events for their 
potential  role  in contamination  and transmission of diseases  (Rozin  et al.,  1993), 
often in relation to food. Opiate users are at particularly high risk of disease, firstly 
due  to  the  lifestyle  they  lead  (e.g.  injecting  heroin,  sleeping rough)  but  secondly 
because  opiates  suppress  the  immune  system  (Vallejo,  de  Leon-Casasola  & 
Benyamin, 2004), leaving users more open to infection and illness. This would make 
heightened  awareness  of  others’  disgust  particularly  valuable  for  protecting 
themselves against potentially contaminating stimuli.
Power and Dalgleish  (1997)  argue that our understanding of disgust in relation to 
contaminating foodstuffs and disease has been over-emphasized at the expense of the 
potentially  more  interesting  application  of disgust  to  the  self and  other  people. 
Disgust seems to serve an important function in negative socialisation (Rozin et al., 
1993), with Rozin and Fallon (1987) noting that disgust is one of the most powerful 
ways of transmitting cultural and moral values.  The typical opiate-user encounters a 
great deal of stigma and negative attention from society (Bell, Dru, Fischer, Levit & 
Sarfraz, 2002; Viney, Westbrook & Preston, 1985), which often involves reactions of 
disgust  (Payte,  Khuri,  Joseph  &  Woods,  1999;  Thaca,  1997).  It  could  be 
hypothesized that this repeated exposure results in hypersensitivity to other’s disgust, 
particularly if a concept of the self as disgusting becomes internalised.
86Johnson-Laird  and  Oatley  (1989)  propose  that  disgust  is  the  key  basic  emotion 
underlying a number of more complex emotions such as  shame.  Moreover, Power 
and Dalgleish (1997) define shame as disgust directed at the self. Shame is defined as 
involving a global negative feeling about the  self in response to  some misdeed or 
shortcoming (Lewis,  1971), and can affect one’s core sense of self (Lindsay-Hartz, 
de Rivera & Mascolo,  1995).  Shame evolved from the need to behave submissively 
to threats  from more powerful  others  (Gilbert,  2000)  and acts to distance the  self 
from others.  One could  speculate that society’s evolutionary socialisation tactic of 
disgust  towards  drug  users  has  resulted  in  them  internalising  this  disgust  and 
experiencing shame. The literature around shame in drug users suggests higher levels 
than in the normal population (Blatt, Rounsaville, Eyre & Wilber,  1984; O’Connor, 
Berry, Inaba, Weiss & Morrison, 1994, Viney et al.,  1985), with Fossum and Mason 
(1986) proposing that “addiction and shame are inseparable”.  Testimonials written 
by  heroin  users  also  describe  intense  feelings  of  shame  (e.g.  “Kerry”,  2004). 
Research in the same clinical setting as the current study also found high levels of 
characterological  shame  in polydrug users compared with non-drug using controls 
(Andersen,  2004).  It has also been suggested that MMs have high levels of shame 
that  predate  the  onset  of substance  use,  and  that while  they use  substances  as  a 
coping strategy for such feelings, their substance use is likely to result in additional 
feelings  of shame  (Dearing,  Stuewig & Tangney, 2005).  This association between 
enhanced disgust recognition and shame is speculative given that no shame measure 
was used in the current study. This is a potentially important area for future research 
to investigate.
87That R participants  showed a different pattern of responding to  disgust compared 
with  MM  participants  is  curious,  as  one  might  expect  this  population  to  have  a 
similar  experience  of  other’s  disgust  reactions  to  MMs.  The  discrepancy  could 
suggest  several  things.  Firstly,  it  is  possible  that the  acute  neuropharmacological 
effects of opiates (and other drugs used) account for the difference between the two 
groups.  As  the  MMs  were  using  a  combination  of different  substances,  it  is  not 
possible  to  accurately  gauge  which  neurotransmitters  or  parts  of the  brain  were 
affected,  making  this  hypothesis  untestable.  Secondly,  it  is  possible  that  the 
immediate  environment  of the  participant  impacts  on  their  sensitivity to  disgust. 
Stigma associated with attending methadone clinics and negative treatment by health 
care workers is well documented (Bell et al., 2002; Payte et al.,  1999). Entering the 
drug  treatment  clinic  in  which MMs  were  tested  may be  sufficient  to  activate  a 
negative  self-concept with heightened feelings of disgust,  directed at both the  self 
and other service users, which could act to prime emotional processing. In contrast, 
the rehabilitation centres used for testing are likely to lack many of those cues and 
the  participants  may  have  access  to  a  healthier  self-concept.  The  process  of 
rehabilitation is also likely to have an impact on self-concept, although it might be 
expected to take more time than had elapsed for many of the R participants.
Alternatively, there may be qualitative differences between MM and R participants 
which enabled the R participants to  enter into the rehabilitation process.  R scored 
comparably with MM on trait and state measures, suggesting that both groups were 
drawn from a similar population. However, MM and R differed in years of exposure 
to opiates and age of first use (MM starting to use earlier and for longer). This could 
indicate  different  reasons  for  using  substances  (e.g.  R  having  fewer  premorbid
88difficulties)  and/or  less  exposure  to  the  lifestyle  associated  with  heroin  use  and 
negative  reactions  of  others.  The  correlation  between  methadone  dose  prior  to 
entering  rehabilitation  and  disgust  recognition  in  R  could  suggest  that  those  Rs 
requiring a higher dose are more like the MM population, given that dose is an index 
of addiction severity (Ghodse, Reynolds, Baldacchino, Dunmore, Byrne, Oyefeso, et 
al., 2002).
Alternatively,  it  is  possible  that  the  mixed  psychopathology  within  the  groups 
accounts  for the  group  difference on  disgust recognition,  rather than the  effect of 
opiate  use.  As  previously  described,  this  population  is  known  to  have  a  high 
incidence  of personality  disorders,  other  substance  use  besides  opiates,  low  self­
esteem and interpersonal difficulties.
Clearly, these are all speculative hypotheses given the scope of the current study and 
the paucity of existing literature. Replication will be important in clarifying whether 
the main finding is robust and what other factors  (e.g.  shame,  emotional priming, 
physical setting) are relevant.
Within MM, participants’ poorer recognition of fear was correlated with increased 
impulsivity, an association that has not been reported in previous studies.  As fear is 
used to  communicate  danger to  others,  a deficit in recognising this,  coupled with 
greater  impulsivity  may  mean  that  individuals  are  less  likely  to  engage  in  harm 
avoidant behaviour.
Subgroup analysis
89i)  Perpetrators of violent crime
Although exploratory given the small and unequal group sizes, the subgroup analysis 
yielded interesting results.  It should be noted that the potential for type  1   errors is 
increased here due to the number of t-tests conducted.  This means that the results 
should be interpreted cautiously.
MM participants who  had perpetrated violent crime  experienced more depression, 
anxiety and stress, reported more impulsivity and aggression and less  socialisation 
than  those  who  had  not.  They  were  also  slower at  responding  to  expressions  of 
happiness.  R  participants  who  had  perpetrated  violent  crime  also  reported  more 
aggression and had lower premorbid IQ scores (Spot-the-Word). Additionally, they 
showed  less  accurate  recognition  of  anger.  It  is  unsurprising  that  increased 
aggression,  impulsivity  and  poor  socialisation  are  associated  with  perpetrating 
violent crime.  The impaired recognition of anger in R perpetrators compared with 
non-perpetrators  of  violent  crime  has  also  been  seen  in  other  populations  (for 
example,  psychopaths,  manic  patients,  alcohol  and benzodiazepine users)  that are 
characterised  by  less  sensitive  social behaviour which  seems  to  take  the  form  of 
aggressive  or persistent approach behaviours.  Intuitively,  it also makes  sense that 
those who transgress social boundaries may be less sensitive to anger, if the function 
of angry expressions is to curtail the ongoing behaviour of others in situations where 
social  rules  have  been  violated  (Averill,  1982).  It  is  unclear  however,  why  this 
impairment would only be present in R participants, not MMs, though small sample 
size could account for this. It is also unclear why MM perpetrators would be slower 
in  recognising  happiness  than  non-perpetrators.  One  could  speculate  that  such  a 
deficit  might  reflect  lower  sensitivity  to  reinforcers  of prosocial  behaviour  (i.e.
90expressions of happiness), making the avoidance of activities such as violent crime 
less important.
ii)  Crack users
While achieving better disgust recognition accuracy scores than R or controls, crack- 
using MMs were  significantly poorer at recognising  disgust than non-crack using 
MMs.  This  difference  is  striking.  One  could  speculate  that  crack-users  form  a 
qualitatively different subgroup who have poorer emotional perception, or that crack 
is  used  in  part  for  its  dampening  effect  on  the  perceptions  of  others’  negative 
emotions. This subgroup also showed significantly less accurate recognition of anger 
and a trend towards reporting more impulsivity than non-crack using MMs. It could 
be  hypothesised  that  the  same  process  underlies  the  crack-using  MMs’  reduced 
accuracy  in  anger  recognition  (as  discussed  in  relation to  perpetrators  of violent 
crime), as the literature suggests that crack use can be associated with violent crime 
(Gossop, 2005; Haynes,  1998) where heroin use alone is not (Hammersley, Forsyth, 
Morrison, & Davies,  1989; Parker & Newcombe  1987). Unfortunately, due to small 
subgroup  size  it is not possible to analyse the relationship between crack use and 
violent  crime.  It  is  also  noteworthy  that  crack  cocaine  use  affects  the 
neurotransmitter dopamine which is thought to play a role in appetitive aggression 
and social dominance (Lawrence, Calder, McGowan & Grasby, 2002).
Limitations, implications and future directions of the study
Although  the  samples  used  in  the  current  study  were  not  purely  methadone 
maintained and ex-opiate using individuals, nor homogenous in terms of their drug 
and alcohol use, they do provide an ecologically valid look at the typical opiate-using
91drug  service  user.  Small  sample  sizes  preclude  firm  conclusions  being  drawn 
regarding the subgroups.
It would be interesting,  given the  lesion and neuroimaging studies  suggesting that 
recognition  of disgust  involves  the  basal  ganglia  (Adolphs,  2002),  anterior insula 
(Calder, Keane, Manes, Antoun & Young, 2000; Phillips, Young, Senior, Brammer, 
Andrews, Calder, et al.,  1997), and caudate (Gray, Young, Barker, Curtis & Gibson, 
1997; Phillips et al., 1997), to compare methadone maintained and rehab participants 
in  fMRI.  The  hypothesis  would  be  that  methadone  maintained  participants  show 
enhanced activation in these areas, in response to disgust expressions.
In order to support the hypothesised meaning of enhanced disgust recognition, future 
research should aim to clarify both the relationship between recognition of disgust 
and feelings of shame,  as well as the experience of shame in this population.  The 
findings  of the present study also point to the  importance of investigating service 
users’  experience of the physical setting in which they receive treatment, and how 
this might impact upon their journey through treatment.
Methadone maintained individuals’  heightened perception of disgust has important 
implications  for  service  providers.  Staff  need  to  be  aware  of  their  non-verbal 
reactions to clients, and, if supported by further research evidence, of the potential 
they and the  environment in which they work have to  evoke feelings of shame in 
their  clients.  Such  feelings  are  likely  to  be  extremely  aversive  and  could  be 
implicated in treatment dropout (Viney et al., 1985).
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109Chapter 3: Critical appraisal
A reflection on the research process
At the start of this research, intentions were clear. Two groups of opiate using clients, 
one  current and one abstinent,  would be tested for their recognition of emotional 
facial expressions. These clients would not be using any other substances or alcohol 
as this would make any results difficult to link directly to opiate use. However, as 
recruitment  began,  it  became  clear  that  this  was  just  not  a  clinical  reality. 
Keyworkers  at  the  treatment  centre  initially  looked  through  their  caseloads  to 
identify potentially  suitable participants,  but  as  the  list of exclusion criteria  were 
applied to each candidate, names were crossed off one by one. Certainly in the group 
of methadone maintained clients served by this North London treatment centre, there 
were few who did not additionally use some combination of crack, benzodiazepines, 
cannabis  and/or  alcohol.  Therefore  a  pragmatic  decision  was  taken  to  include 
participants  with  some  concomitant  drug  use,  which  also  served  to  improve  the 
ecological validity of the study (this is discussed in more detail later).
This highlights how unfamiliar with the area of substance misuse I was prior to this 
research, and how much I learnt about this client group over the year-long process of 
recruitment. A more careful look at the profile of service users while formulating my 
research question would have been prudent.
The  recruitment  involved  in  conducting  this  research  was  arduous,  given  the 
methadone  maintained  client  group.  While  they  were  very  pleasant,  warm 
individuals, they were amongst the most disorganised and difficult to access that I
110have come across doing research. The transient lifestyles that they lead do not lend 
them to being reliable participants;  appointments with drug treatment staff are the 
only appointments that many of them have in their lives, and they find these hard to 
keep,  instead using an informal  ‘drop-in’  system. Anecdotally,  the DNA rate with 
this population tends to be around 50%. Many participants also found it difficult to 
be in a room concentrating for the one and a half hours that testing required; this was 
certainly a factor that discouraged many from participating. On the whole, those who 
did take part initially seemed to see it as a favour to their drugs worker. Additional 
use  of drugs  and alcohol  also  proved a problem,  as  some participants arrived  for 
testing having recently used alcohol or crack,  and had to be asked to return when 
sober.
In  the  methadone  maintained  group,  for  some  the  interview  process  was  an 
opportunity to talk to somebody outside of their world who did not have the same 
time pressures as treatment centre staff. The use of a mood state measure frequently 
led to discussion of how they were feeling and difficulties they were going through. 
The need to be vigilant for signs of significant distress or suicidal thoughts, and to 
deal  with these  appropriately and responsibly was  clear.  In gathering  information 
regarding history of drug use and crime, participants ended up sharing many of their 
experiences, both positive and negative. Some participants enjoyed this while others 
found it distressing.  A great deal of personal  information was  shared  during each 
testing session, which enriched the research process and gave me a window into a 
client group  that I  previously knew little  about.  Certainly one  of the most useful 
learning points of the study was my increased awareness of the highly complex needs 
of this client group.
IllConsideration was given to the ethical dilemma of offering payment to methadone 
maintained participants. As a drug-using population in receipt of little income, there 
was a question over whether participants would take part irrespective of whether they 
wished to, in order to receive die payment. In order to maximise informed consent, 
participants were given time to consider the study which was then explained fully. I 
was  also  aware of the possibility that payment would be  exchanged  for drugs  on 
leaving the site. Therefore, payment was given in the form of supermarket vouchers 
in order to encourage the purchase of non-drug items.
Testing  the  rehab  participants  was  a  very  different  experience  to  testing  the 
methadone maintained group. I tested them after the methadone maintained group, 
which  gave  a  feeling  of progression to  the  process.  Having  seen the  entrenched 
difficulties faced by the first group, it was a relief to see that there could be a ‘next 
stage’. This made me feel less despondent about the apparent hopelessness of those 
caught in the cycle of serious drug use.
While  the  rehabilitation  programmes  used  for  recruitment  varied  in  length, 
therapeutic style and whether they were daytime-only or residential, they all offered 
clients an intensive therapeutic experience in a pleasant, empathic setting. Although 
testing  had  to  be  carefully  scheduled  around  therapy  groups  and  community 
meetings, clients were eager to participate in their free time and receive payment that 
would be spent on things other than drugs. Several told me that they had participated 
in research during their drug-using days, and exchanged their voucher payment for
112some  drug-related  commodity.  They  were  pleased  to  be  able  to  do  something 
different this time.
Some participants had entered rehab relatively recently (i.e.  6 weeks before) while 
others  were  approaching  the  end  after one  year.  This  time  had  been  spent  going 
through  an  intensive  therapeutic  process  which  involved  confronting  many 
unpleasant and long-avoided issues, experiences and aspects of themselves. Many of 
the clients had become used to  ‘telling their story’  about drug use and themselves, 
which often poured out during interviewing,  giving me an insight into the changes 
that occur in how people see their drug use at different stages of use.  For example, 
one  of the  questions  used  to  elicit  information  about  the  severity  of other  drug 
problems was “and has your x use ever been problematic, as you see it?” Where the 
current drug-using group invariably answered “no”, particularly regarding cannabis 
and alcohol,  the clients in rehab  invariably responded “if you’d have asked me x 
months ago, I would have said no, but now I would say without a doubt, yes”.
Two rehab participants reported that they had found the interview unpleasant, due to 
memories of their past lives and selves that they would rather forget, being prompted 
by my questions about past drug use. It might be relevant that these two participants 
were two  of the  four who were  enrolled in the day rehab programme.  One  could 
speculate  that  day  programmes  make  continued  avoidance  easier  than  their 
residential counterparts, which immerse clients in the therapeutic process to a greater 
degree. Of the remainder of the participants, most commented that they had enjoyed 
the interview, saying that it had been interesting to do something different.
113I was fortunate enough to be able to share the recruitment and interviewing process 
with a  fellow trainee  clinical psychologist who  was  conducting  research with the 
same population. This certainly added to my experience of the research.  We were 
able to help maintain each other’s motivation and interest through the difficult times 
in recruitment in the way of a ‘tag-team’, and share the thrill of completing testing 
after a year of hard work.  However, this meant that I did not test all the participants 
myself, and did not get the experience of testing the control group.
This research was initially approached from a pharmacological theoretical viewpoint, 
i.e. that the pharmacological changes brought about by opiate use were likely to have 
an impact on FER, as in other populations with altered neurotransmitter functioning. 
Literature  in  the  area  of facial  expression recognition  leans  quite  heavily  in  this 
direction,  although  more  recent  research  seems  to  be  integrating  the 
neuropharmacological  with the  psychological  to  a  greater extent.  When trying  to 
interpret the results of this study, it became clear that there were so many potential 
pharmacological effects brought about by opiate use, and in combination with crack 
or benzodiazepine use, and possibly a history of other chug or alcohol dependence, 
the  results  simply  could  not  be  attributed  purely  to  direct  opiate  action.  It  also 
became clear that characteristics of the population such as their upbringing, current 
living  environment,  antisocial  behaviour,  low  self-esteem  and  psychological 
difficulties were likely to have a significant impact on perception of emotion.
Additionally, spending so much time in the treatment centre gave a flavour of how it 
must feel to be a service user, with all that this entails for one’s sense of identity. It is 
a  large  intimidating  building  located  in  an  inner  city  area,  towards  which  local
114residents are hostile,  and there are groups of service users drinking cans of strong 
lager congregating outside.  Inside, a security guard, restricted entry and a partition 
between staff and clients, and most strikingly of all a smell that fluctuates between 
mildly unpleasant and abject rotting. The service provides treatment for the highest 
number of methadone maintained clients in the UK, many of whom are homeless and 
suffer significant psychological, social, legal and health problems. It should be said 
that the staff are highly skilled and work hard to counter this aversive environment. 
However,  the  experience  of being  in  this  environment  (also  where  testing  was 
conducted)  seems  very  relevant,  especially  when  discussing  a  result  such  as 
enhanced recognition of disgust.  This was in comparison to the clean, welcoming, 
well  decorated,  Edwardian and Tudor buildings that  constituted the  rehabilitation 
centres.  In  this  way,  psychological  and  social  factors  began  to  seem  at  least  as 
relevant as the neuropharmacological as the study progressed.
Critical Appraisal
The  main  finding  of  the  study  was  that  opiate  users  demonstrated  enhanced 
recognition of other peoples’ disgust expressions. This finding is striking given that 
enhanced FER has rarely been reported in the vast literature on FER in psychiatric, 
neurologically  impaired  and  drug-using  populations.  Moreover,  the  literature 
surrounding the expression of disgust paints a picture that is so inconclusive that it is 
unclear  what  such  a  finding  might  mean.  There  are  theoretical  indications  that 
disgust may be important in negative socialisation, theoretical and (some) empirical 
evidence that disgust is an important emotion in OCD (Power and Dalgleish,  1997), 
and  empirical  evidence  of  enhanced  disgust  recognition  in  bipolar  individuals
115(Harmer,  Grayson &  Goodwin,  2002).  However,  the  literature  does  not  draw the 
evidence together in a meaningful way.
I have speculated about the possible roles of neuropharmacological changes due to 
opiate use, the possible survival advantage of enhanced disgust recognition conferred 
to  opiate  users  due  to  their  living  environment  and  consequent  susceptibility  to 
illness, hypersensitivity of this population to others’ disgust reactions and a possible 
connection with  shame.  Beyond  this,  the  paucity  of literature  in  this  area  makes 
conclusions  difficult  to  draw.  Replication  of this  study  is  now  needed,  with  the 
addition of measures of self-perception and shame. It is clear that more research into 
the function of disgust with regard to psychopathology and social functioning would 
illuminate our understanding of this phenomenon.
Methadone maintained individuals’ heightened perception of disgust has important 
implications  for  service  providers.  Staff  need  to  be  aware  of  their  non-verbal 
reactions to clients, and if supported by further research evidence, of the potential 
that they and the environment in which they work, have to evoke feelings of shame 
in  their  clients.  Such  feelings  are  likely  to  be  extremely  aversive  and  could  be 
implicated in treatment dropout (Viney, Westbrook & Preston,  1985). If it is found 
that  enhanced  disgust  recognition  is  a  measure  of shame,  this  provides  further 
support regarding the need for shame-based interventions with this population.
The clients used in this study were not homogenous in their drug use or purely-opiate 
using,  meaning  that  it  is  difficult to  draw  tight theoretical  conclusions  about the 
effects of opiates on the basis of any results. However the clinical usefulness of any
116conclusions drawn from such a homogeneous sample would be questionable, as this 
population  is  so  rarely  seen  in  real-life  settings.  A  considerable  strength  of the 
current study is the degree of ecological validity it attains due to the samples used. 
Limits were set on how frequent and problematic additional drug use was, in order to 
minimise  the  effect  of other  factors  such  as  crack  use.  This,  in  addition  to  the 
motivational  (i.e.  being  interested),  organisational  (i.e.  turning  up  for  a  testing 
appointment) and time requirements of the testing procedure (one and a half hours), 
necessarily created a selection bias in favour of the less chaotic clients. In this sense, 
the sample used in this study are likely to represent the more stable end of the opiate- 
using spectrum seen for treatment in North London. This said, a more representative 
sample simply was not testable.
The comparability of the groups also adds to the validity of the  current study. As 
demonstrated  by  the  demographic  measures  used,  the  rehab  group  was  broadly 
equivalent to the methadone maintained group. The only difference between the two 
clinical groups seems to have been the age of onset of opiate use and length of opiate 
exposure. It is possible that this is an indicator of qualitative differences between the 
groups,  although  this  could  only  be  verified  using  a  measure  of  pre-morbid 
functioning. That the control group consisted of unemployed individuals living in a 
similar inner-city area also adds to the comparability of the groups. Additionally, the 
use  of urine  screening  with  the  clinical  groups  confirmed  their  current  drug use 
status. All of these features increase the potential for meaningful conclusions to be 
drawn.
117The  use  of all  male  samples  was  important  for  several  reasons.  Firstly,  gender 
differences have been shown in FER ability, with women outperforming men on tests 
of emotion recognition (Hall,  1978; Montagne, Kessels, de Geus, Denys, de Haan, 
Westenberg,  et al., 2005).  Secondly, research indicates that men and women with 
substance  misuse  problems  may  enter  treatment  with  different  problems  and 
emotional needs. Women and men in treatment have also been found to differ in their 
use  of  substances  other  than  heroin,  interpersonal  relationships,  drug  dealing, 
employment and criminal behaviours (Anglin & Hser,  1987), as well as with respect 
to  why  they  started  using  drugs  (Dobler-Mikola  &  Zimmer-Hofler,  1993).  In 
addition,  a  higher  incidence  of depression  has  also  been  found  in  drug-addicted 
women than men (O’Connor, Berry, Inaba, Weiss & Morrison, 1994). Therefore, the 
use of a purely male sample reduced variability not due to opiate use.
Although not  the primary  focus  of the  study,  the  collection of information about 
involvement  in  violent  crime  and the  use  of measures  such as  the AQ,  BIS  and 
Gough  build  an  interesting  profile  of  the  type  of  clients  using  drug  treatment 
services. That the picture which emerged fits with existing research findings again 
improves the validity of this study.
Conducting this research, alongside completing a clinical placement in the substance 
misuse  service  from which the  methadone maintained  sample were recruited,  has 
fuelled my interest in working  clinically with this population post-qualification.  I 
also have a better grasp of the potential difficulties involved in conducting research 
with  this  client  group,  and  how  to  minimise  these  pitfalls.  This  is  an  under­
researched  client  group,  due  no  doubt  in  part  to  the  difficulties  I  have  already
118described, but one with complex needs,  including a significant prevalence of dual 
diagnosis. More research in clinical settings will be important in better understanding 
these needs, both for individual client work and service planning.  This is true for 
most areas of clinical psychology practice, where, in my experience through training 
placements,  research  conducted  alongside  clinical  work  is  simply not  a  reality.  I 
would hope to be able to incorporate my research skills into my clinical work with 
this client group in the future. In reviewing the literature for this thesis, a particularly 
interesting  area  in  which  little  research has  been  conducted  was  highlighted:  the 
process of change that service users undergo as they make the transition from user to 
ex-user via rehab. For example, the motivational factors that prompt the decision to 
change, the changes in how they perceive their drug use and their sense of self, as 
well  as  what  it  is  that  they  undergo  in  rehab  that  helps  or  does  not  help  with 
abstinence would all make for interesting future research.
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122Camden & Islington Community Health Services Local Research Ethics Committee
LREC Ref: 03/106
PRIVATE AND CONFIDENTIAL
Professor V Curran
Sub-Department of Clinical Health Psychology 
University College London 
30 March 2004
Dear Professor Curran
Title: Methadone maintenance and the interpretation of sentences and emotions.
Thank you for your email of 26th March 2004, which addressed the points raised by the Ethics Committee at their 
meeting on 23rd February 2004.1  am pleased to inform you that after careful consideration the Local Research 
Ethics Committee has no ethical objections to your project proceeding. This opinion has also been communicated 
to the North Central London Community Research Consortium.
PLEASE NOTE THAT THIS OPINION ALONE DOES NOT ENTITLE YOU TO BEGIN RESEARCH. YOU MUST 
RECEIVE AISLAPPRQVAL FROM EACH NHS TRUST HOSTING YOUR RESEARCH.
Camden and Islington Community Health Service LREC considers the ethics of proposed research projects and 
provides advice to NHS bodies under the auspices of which the research is intended to take place. It is that NHS 
body which has the responsibility to decide whether or not the project should go ahead, taking into account the 
ethical advice of the LREC1. Where these procedures take place on NHS premises or using NHS patients, the 
researcher must obtain the agreement of local NHS management, who will need to be assured that the researcher 
holds an appropriate NHS contract, and that indemnity issues have been adequately addressed.
N.B. Camden and Islington Community Health Service LREC is an independent body providing advice to the North 
Central London Community Research Consortium.  A favourable opinion from the LREC and approval from the 
Trust to commence research on Trust premises or patients are NOT one and the same.  Trust approval is notified 
through the Research & Development Unit (please see attached flow chart).
The following conditions apply to this project:
♦  You must write and inform the Committee of the start date of your project. The Committee (via the Local 
Research Ethics Committee Administrator or the Chair at the above address) must also receive notification:
a) when the study commences;
b) when the study is complete;
c) if it fails to start or is abandoned;
1  Governance Arrangements for NHS Research Ethics Committees, July 2001 (known as GAFREC) 
An advisory committee to North Central London Strateaie Health Authorityd) if the investigator/s change and
e) if any amendments to the study are made.
\ / ^
NHS
2
♦  The Committee must receive immediate notification of any adverse or unforeseen circumstances arising out of
♦  It is the responsibility of the investigators to ensure that all associated staff, including nursing staff, are 
informed of research projects and are told that they have the approval of the Ethics Committee and 
management approval from the body hosting the research.
♦  The Committee will require a copy of the report on completion of the project and may request details of the 
progress of the research project periodically (i.e. annually for longer projects).
♦  If data is to be stored on a computer in such a way as to make it possible to identify individuals, then the  project
must be registered under the Data Protection Act 1998.  Please consult your department data protection officer
♦  Failure to adhere to these conditions set out above will result in the invalidation of this letter of no objection.
Please forward any additional information/amendments regarding your study to the Local Research Ethics
Committee Administrator or the Chair at the above address.
Yours sincerely
LREC Chair
Email:   (administrator) 
Enc/s:
Copy to:
the project.
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Participant Information Sheet (methadone maintained clients)Participant information sheet
Research Study: Methadone and the interpretation of sentences and emotions
Researchers: Louise Martin and Jo Coyle (Trainee Clinical Psychologists)
You are invited to take part in a research study. Before you decide, it is important for you to understand why the 
research is being done and what it will involve. Please read the following information. Please ask us if there is 
anything that is unclear or if you would like more information. Take time to decide whether you wish to take part.
What is the purpose of the research project?
To understand what effect methadone has on the way people understand sentences and facial expressions. Research 
has shown that different drugs affect these two things. In this study we are looking at 1) people who use methadone 
at the moment, 2) people who no longer use methadone or heroin, and 3) people who have never used methadone.
Why have I been chosen?
We have asked you to take part in the study because you are using methadone at the moment. We will also be 
approaching around 30 other people who currently use methadone.
Do I have to take part?
You do not have to take part in this study if you do not wish to. Your decision to take part will not affect your care 
management in any way. If you do decide to take part you will be given this information sheet to keep and be asked 
to sign a consent form. If you do decide to take part, you can withdraw at any time without having to give a reason.
What will happen if I take part?
We will arrange to meet you once for about 1-hour at the Margarete Centre, after you have taken your methadone. 
First we will ask you a little about your drug use. You will then be shown some sentences and faces on a computer 
and asked to make some decisions about them. We will also ask you to complete some questionnaires and provide a 
urine sample. When this is completed, we will give you a voucher worth £6. All information collected about you 
during the study is strictly confidential and will be coded by number. Your name will not appear on any forms.
What are the advantages and disadvantages of taking part?
We do not foresee that taking part will cause you distress. We hope that the information we collect from this study 
will improve our understanding of the effects of methadone, and so help to improve services to methadone clients.
What will happen to the results of the study?
The results will be written up as part of a thesis, which we hope will be published in a scientific journal. A summary 
of the findings will be available to all who took part.
Who is organising and funding the study?
The study is organised and funded by Camden and Islington NHS Trust and University College London.
Contact for further information:
If you would like further information or have any questions, then please leave a message for us at the Margarete 
Centre.
Thank you for taking time to read this.
Date:  14th July 2004
All proposals for research using human subjects are reviewed by an ethics committee before they can proceed. This 
proposal was reviewed by Camden and Islington Health Services NHS Trust Ethics Committee.Appendix J
Participant Information Sheet (rehab clients)MA
Participant information sheet (opiate abstinent clients'!
(CORE Trust)
Research Study: Methadone maintenance and the interpretation of sentences and emotions
Researchers: Louise Martin and Joanna Coyle
You are invited to take part in a research study. Before you decide, it is important for you to understand why the research 
is being done and what it will involve. Please read the following information. Please ask us if there is anything that is 
unclear or if you would like more information. Take time to decide whether you wish to take part.
What is the purpose of the research project?
To understand what effect using methadone has on the way people interpret sentences and facial expressions. Research 
has  shown  that  different drugs  affect these two functions.  In this  study,  we  are  looking  at  1)  people  who  are  using 
methadone at the moment, 2) people who no longer use methadone or heroin, and 3) people who have never used.
Why have I been chosen?
We have asked you to take part in the study because you are no longer using methadone or heroin.  We will  also be 
approaching around 20 other people who are currently abstinent.
Do I have to take part?
You do not have to take part in this study if you do not wish to. Your decision to take part will not affect your healthcare 
or management in any way. If you do decide to take part you will be given this information sheet to keep and be asked to 
sign a consent form. If you do decide to take part, you can withdraw at any time without having to give a reason.
What will happen if I take part?
We will arrange to meet you once for around 1  hour at the CORE Trust. First we will ask you a little about yourself and 
your drug use. Then we will ask you to complete some questionnaires. After this you will spend around half an hour 
doing some tasks on  a computer. These will  include making decisions about sentences and faces that you are shown. 
When this is completed, we will give you a voucher worth £6. We would like to take a urine sample, just to confirm that 
you are not using drugs. The results of this would be confidential and not fed back to the CORE Trust. All information 
collected about you during the study is strictly confidential and will be coded by number. Your name will not appear on 
any forms.
What are the advantages and disadvantages of taking part?
We do not foresee that taking part will cause you distress. We hope that the information we collect from this study will 
improve our understanding of the effects of methadone, and have implications for improving services to clients.
What will happen to the results of the study?
The results will be written up as part of a thesis, which we hope will be published in a scientific journal. A summary of 
the findings will be available to all who took part.
Who is organising and funding the study?
The study is organised and funded by Camden and Islington NHS Trust and University College London.
Contact for further information:
If you would like further information or have any questions, you can contact us at the Margarete Centre on 020 75303086.
Thank you for taking time to read this.
Date:  15.12.04
All  proposals  for research  using human  subjects are reviewed  by an  ethics  committee before they can proceed.  This 
proposal was reviewed by Camden and Islington Health Services NHS Trust Ethics Committee.Appendix K
Consent Form (both methadone maintained and rehab clients)Participant identification code:
Consent Form (Methadone maintained and opiate abstinent clients)
Confidential
Research Study: Methadone maintenance and the interpretation of sentences and emotions
Name of researchers: Louise Martin and Joanna Coyle
1.  I confirm that I have read and that I understand the information sheet dated__________ for the
above study.
YES/NO
2.  I have had an opportunity to ask questions and discuss this study.
YES/NO
3.  I understand that I am free to withdraw from this study:
■   at any time
■   without reason
■   without affecting my healthcare and management at the Margarete Centre.
YES/NO
4.  I agree to take part in the above study.
YES/NO
Name of participant  Date  Signature of participant
Researcher Date Signature of researcher